<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml" xml:lang="en" lang="en">
    
    <head><meta http-equiv="Content-Type" content="text/html; charset=utf-8" />
        <!-- AppResources meta begin -->
        <meta name="paf-app-resources" content="" />
                 <script type="text/javascript">var ncbi_startTime = new Date();</script>
            
        <!-- AppResources meta end -->
        
        <!-- TemplateResources meta begin -->
        <meta name="paf_template" content="" />

        <!-- TemplateResources meta end -->
        
        <!-- Logger begin -->
        <meta name="ncbi_db" content="books" /><meta name="ncbi_pdid" content="book-part" /><meta name="ncbi_acc" content="NBK1268" /><meta name="ncbi_domain" content="gene" /><meta name="ncbi_report" content="record" /><meta name="ncbi_type" content="fulltext" /><meta name="ncbi_objectid" content="" /><meta name="ncbi_pcid" content="/NBK1268/" /><meta name="ncbi_pagename" content="Spinocerebellar Ataxia Type 8 - GeneReviews® - NCBI Bookshelf" /><meta name="ncbi_bookparttype" content="chapter" /><meta name="ncbi_app" content="bookshelf" />
        <!-- Logger end -->
        
        <title>Spinocerebellar Ataxia Type 8 - GeneReviews® - NCBI Bookshelf</title>
        
        <!-- AppResources external_resources begin -->
        <link rel="stylesheet" href="/core/jig/1.14.8/css/jig.min.css" /><script type="text/javascript" src="/core/jig/1.14.8/js/jig.min.js"></script>

        <!-- AppResources external_resources end -->
        
        <!-- Page meta begin -->
        <meta name="robots" content="INDEX,FOLLOW,NOARCHIVE" /><meta name="citation_inbook_title" content="GeneReviews® [Internet]" /><meta name="citation_title" content="Spinocerebellar Ataxia Type 8" /><meta name="citation_publisher" content="University of Washington, Seattle" /><meta name="citation_date" content="2014/04/03" /><meta name="citation_author" content="Fatma Ayhan" /><meta name="citation_author" content="Yoshio Ikeda" /><meta name="citation_author" content="Joline C Dalton" /><meta name="citation_author" content="John W Day" /><meta name="citation_author" content="Laura PW Ranum" /><meta name="citation_pmid" content="20301445" /><meta name="citation_fulltext_html_url" content="https://www.ncbi.nlm.nih.gov/books/NBK1268/" /><meta name="citation_keywords" content="SCA8" /><meta name="citation_keywords" content="SCA 8" /><meta name="citation_keywords" content="SCA8" /><meta name="citation_keywords" content="Ataxin-8" /><meta name="citation_keywords" content="ATXN8" /><meta name="citation_keywords" content="ATXN8OS" /><meta name="citation_keywords" content="Spinocerebellar Ataxia Type 8" /><link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /><meta name="DC.Title" content="Spinocerebellar Ataxia Type 8" /><meta name="DC.Type" content="Text" /><meta name="DC.Publisher" content="University of Washington, Seattle" /><meta name="DC.Contributor" content="Fatma Ayhan" /><meta name="DC.Contributor" content="Yoshio Ikeda" /><meta name="DC.Contributor" content="Joline C Dalton" /><meta name="DC.Contributor" content="John W Day" /><meta name="DC.Contributor" content="Laura PW Ranum" /><meta name="DC.Date" content="2014/04/03" /><meta name="DC.Identifier" content="https://www.ncbi.nlm.nih.gov/books/NBK1268/" /><meta name="description" content="SCA8 is a slowly progressive ataxia with disease onset typically occurring in adulthood. Onset ranges from age one to 73 years. The progression is typically over decades regardless of the age of onset. Common initial symptoms are scanning dysarthria with a characteristic drawn-out slowness of speech and gait instability; life span is typically not shortened. Some individuals present with nystagmus, dysmetric saccades and, rarely, ophthalmoplegia. Tendon reflex hyperreflexity and extensor plantar responses are present in some severely affected individuals. Life span is typically not shortened." /><meta name="og:title" content="Spinocerebellar Ataxia Type 8" /><meta name="og:type" content="book" /><meta name="og:description" content="SCA8 is a slowly progressive ataxia with disease onset typically occurring in adulthood. Onset ranges from age one to 73 years. The progression is typically over decades regardless of the age of onset. Common initial symptoms are scanning dysarthria with a characteristic drawn-out slowness of speech and gait instability; life span is typically not shortened. Some individuals present with nystagmus, dysmetric saccades and, rarely, ophthalmoplegia. Tendon reflex hyperreflexity and extensor plantar responses are present in some severely affected individuals. Life span is typically not shortened." /><meta name="og:url" content="https://www.ncbi.nlm.nih.gov/books/NBK1268/" /><meta name="og:site_name" content="NCBI Bookshelf" /><meta name="og:image" content="https://www.ncbi.nlm.nih.gov/corehtml/pmc/pmcgifs/bookshelf/thumbs/th-gene-lrg.png" /><meta name="twitter:card" content="summary" /><meta name="twitter:site" content="@ncbibooks" /><meta name="bk-non-canon-loc" content="/books/n/gene/sca8/" /><link rel="canonical" href="https://www.ncbi.nlm.nih.gov/books/NBK1268/" /><link rel="stylesheet" href="/corehtml/pmc/css/figpopup.css" type="text/css" media="screen" /><link rel="stylesheet" href="/corehtml/pmc/css/bookshelf/2.22/css/books.min.css" type="text/css" /><link rel="stylesheet" href="/corehtml/pmc/css/bookshelf/2.22/css/books_print.min.css" type="text/css" media="print" /><style type="text/css">p a.figpopup{display:inline !important} .bk_tt {font-family: monospace}  .first-line-outdent .bk_ref {display: inline}  .body-content h2, .body-content .h2  {border-bottom: 1px solid #97B0C8} .body-content h2.inline {border-bottom: none} a.page-toc-label , .jig-ncbismoothscroll a {text-decoration:none;border:0 !important} .temp-labeled-list  .graphic {display:inline-block !important} .temp-labeled-list  img{width:100%}</style><script type="text/javascript" src="/corehtml/pmc/js/jquery.hoverIntent.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/common.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/large-obj-scrollbars.min.js"> </script><script type="text/javascript">window.name="mainwindow";</script><script type="text/javascript" src="/corehtml/pmc/js/bookshelf/2.22/book-toc.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/bookshelf/2.22/books.min.js"> </script><meta name="book-collection" content="NONE" />

        <!-- Page meta end -->
    <link rel="shortcut icon" href="//www.ncbi.nlm.nih.gov/favicon.ico" /><meta name="ncbi_phid" content="CE8C6712E03F696100000000086F02D2.m_12" />
<meta name='referrer' content='origin-when-cross-origin'/><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/css/3852956/3985586/3808861/4121862/3974050/3917732/251717/4098876/14534/45193/4113719/3849091/3984811/3751656/4033350/3840896/3577051/3852958/4008682/3881636/3579733/4062871/12930/3964959/3854974/36029/4128070/9685/3549676/3609192/3609193/3609213/3395586.css" /><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/css/3411343/3882866.css" media="print" /></head>
    <body class="book-part">
        <div class="grid">
            <div class="col twelve_col nomargin shadow">
                <!-- System messages like service outage or JS required; this is handled by the TemplateResources portlet -->
                <div class="sysmessages">
                    <noscript>
	<p class="nojs">
	<strong>Warning:</strong>
	The NCBI web site requires JavaScript to function. 
	<a href="/guide/browsers/#enablejs" title="Learn how to enable JavaScript" target="_blank">more...</a>
	</p>
	</noscript>
                </div>
                <!--/.sysmessage-->
                <div class="wrap">
                    <div class="page">
                        <div class="top">
                            <div class="universal_header" id="universal_header"><ul class="inline_list jig-ncbimenu ui-ncbimenu resources_list" id="navcontent"><li class="ui-ncbimenu-item-leaf ui-ncbimenu-item-first ui-helper-reset ui-ncbimenu-item-no-hlt"><a class="ui-ncbimenu-link-first" href="/" role="banner" title="NCBI Home" id="ncbihome" accesskey="1"><span class="offscreen_noflow">NCBI</span><img src="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/img/28977" class="ncbi_logo" title="NCBI" alt="NCBI Logo" /></a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="#maincontent" title="Skip to the content" tabindex="0" accesskey="3">Skip to main
                        content</a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="#navcontent" title="Skip to the navigation" tabindex="0" accesskey="4">Skip to
                        navigation</a></li><li id="resource-menu" class="topmenu ui-helper-reset ui-ncbimenu-item-first ui-helper-reset"><a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="/static/header_footer_ajax/submenu/#resources">Resources</a></li><li id="all-howtos-menu" class="topmenu ui-helper-reset ui-ncbimenu-item-first"><a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="/static/header_footer_ajax/submenu/#howto">How To</a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="/guide/browsers/#accesskeys" title="About My NCBI Accesskeys" tabindex="0" accesskey="0">About NCBI Accesskeys</a></li></ul><div class="myncbi"><span id="myncbiusername" style="display:none"><a href="/account/settings/" id="mnu" title="Edit account settings"></a></span><a accesskey="2" href="/myncbi/" id="myncbi" style="display:none">My NCBI</a><a href="/account/" id="sign_in">Sign in to NCBI</a><a href="/account/signout/" id="sign_out" style="display:none">Sign Out</a></div></div>
                            <div class="header">
    <div class="res_logo"><h1 class="res_name"><a href="/books/" title="Bookshelf home">Bookshelf</a></h1><h2 class="res_tagline"></h2></div>
    <div class="search"><form method="get" action="/books/"><div class="search_form"><label for="database" class="offscreen_noflow">Search database</label><select id="database"><optgroup label="Recent"><option value="books" selected="selected" class="last" data-ac_dict="bookshelf-search">Books</option></optgroup><optgroup label="All"><option value="gquery">All Databases</option><option value="assembly">Assembly</option><option value="biocollections">Biocollections</option><option value="bioproject">BioProject</option><option value="biosample">BioSample</option><option value="biosystems">BioSystems</option><option value="books" data-ac_dict="bookshelf-search">Books</option><option value="clinvar">ClinVar</option><option value="cdd">Conserved Domains</option><option value="gap">dbGaP</option><option value="dbvar">dbVar</option><option value="gene">Gene</option><option value="genome">Genome</option><option value="gds">GEO DataSets</option><option value="geoprofiles">GEO Profiles</option><option value="gtr">GTR</option><option value="homologene">HomoloGene</option><option value="ipg">Identical Protein Groups</option><option value="medgen">MedGen</option><option value="mesh">MeSH</option><option value="ncbisearch">NCBI Web Site</option><option value="nlmcatalog">NLM Catalog</option><option value="nuccore">Nucleotide</option><option value="omim">OMIM</option><option value="pmc">PMC</option><option value="popset">PopSet</option><option value="probe">Probe</option><option value="protein">Protein</option><option value="proteinclusters">Protein Clusters</option><option value="pcassay">PubChem BioAssay</option><option value="pccompound">PubChem Compound</option><option value="pcsubstance">PubChem Substance</option><option value="pubmed">PubMed</option><option value="snp">SNP</option><option value="sparcle">Sparcle</option><option value="sra">SRA</option><option value="structure">Structure</option><option value="taxonomy">Taxonomy</option><option value="toolkit">ToolKit</option><option value="toolkitall">ToolKitAll</option><option value="toolkitbookgh">ToolKitBookgh</option></optgroup></select><div class="nowrap"><label for="term" class="offscreen_noflow" accesskey="/">Search term</label><div class="nowrap"><input type="text" name="term" id="term" title="Search Books. Use up and down arrows to choose an item from the autocomplete." value="" class="jig-ncbiclearbutton jig-ncbiautocomplete" data-jigconfig="dictionary:'bookshelf-search',disableUrl:'NcbiSearchBarAutoComplCtrl'" autocomplete="off" data-sbconfig="ds:'no',pjs:'no',afs:'no'" /></div><button id="search" type="submit" class="button_search nowrap" cmd="go">Search</button></div></div></form><ul class="searchlinks inline_list"><li>
                        <a href="/books/browse/">Browse Titles</a>
                    </li><li>
                        <a href="/books/advanced/">Advanced</a>
                    </li><li class="help">
                        <a href="/books/NBK3833/">Help</a>
                    </li></ul></div>
</div>

                            
                            
                        <!--<component id="Page" label="headcontent"/>-->
                            
                        </div>
                        <div class="content">
                            <!-- site messages -->
                            <!-- Custom content 1 -->
<div class="col1">
    
</div>

<div class="container">
    <div id="maincontent" class="content eight_col col">
        <!-- Custom content in the left column above book nav -->
        <div class="col2">
            
        </div>
        
        <!-- Book content -->
        

        <!-- Custom content between navigation and content -->
        <div class="col3">
            
        </div>
        
        <div class="document">
            <div class="pre-content"><div><div class="bk_prnt"><p class="small">NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.</p><p>Adam MP, Ardinger HH, Pagon RA, et al., editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2019. </p></div><div class="iconblock clearfix whole_rhythm no_top_margin bk_noprnt"><a class="img_link icnblk_img" title="All GeneReviews" href="/books/n/gene/"><img class="source-thumb" src="/corehtml/pmc/pmcgifs/bookshelf/thumbs/th-gene-lrg.png" alt="Cover of GeneReviews®" height="100px" width="80px" /></a><div class="icnblk_cntnt eight_col"><h2>GeneReviews<sup>®</sup> [Internet].</h2><a data-jig="ncbitoggler" href="#__NBK1268_dtls__">Show details</a><div style="display:none" class="ui-widget" id="__NBK1268_dtls__"><div>Adam MP, Ardinger HH, Pagon RA, et al., editors.</div><div>Seattle (WA): <a href="http://www.washington.edu" ref="pagearea=page-banner&amp;targetsite=external&amp;targetcat=link&amp;targettype=publisher">University of Washington, Seattle</a>; 1993-2019.</div></div><div class="half_rhythm"><ul class="inline_list"><li style="margin-right:1em"><a class="bk_cntns" href="/books/n/gene/">GeneReviews by Title</a></li></ul></div><div class="bk_noprnt"><form method="get" action="/books/n/gene/" id="bk_srch"><div class="bk_search"><label for="bk_term" class="offscreen_noflow">Search term</label><input type="text" title="Search GeneReviews" id="bk_term" name="term" value="" data-jig="ncbiclearbutton" /> <input type="submit" class="jig-ncbibutton" value="Search GeneReviews" submit="false" style="padding: 0.1em 0.4em;" /></div></form><div><ul class="inline_list"><li><a href="/books/n/gene/advanced/">GeneReviews Advanced Search</a></li><li style="margin-left:.5em"><a href="/books/n/gene/helpadvsearch/">Help</a></li></ul></div></div></div><div class="icnblk_cntnt two_col"><div class="pagination bk_noprnt"><a class="active page_link prev" href="/books/n/gene/sca7/" title="Previous page in this title">&lt; Prev</a><a class="active page_link next" href="/books/n/gene/sca10/" title="Next page in this title">Next &gt;</a></div></div></div></div></div>
            <div class="main-content lit-style" itemscope="itemscope" itemtype="http://schema.org/CreativeWork"><div class="meta-content fm-sec"><h1 id="_NBK1268_"><span class="title" itemprop="name">Spinocerebellar Ataxia Type 8</span></h1><div itemprop="alternativeHeadline" class="subtitle whole_rhythm">Synonym: SCA8</div><p class="contrib-group"><span itemprop="author">Fatma Ayhan</span>, BS, <span itemprop="author">Yoshio Ikeda</span>, MD, PhD, <span itemprop="author">Joline C Dalton</span>, MS, <span itemprop="author">John W Day</span>, MD, PhD, and <span itemprop="author">Laura PW Ranum</span>, PhD.</p><a data-jig="ncbitoggler" href="#__NBK1268_ai__" style="border:0;text-decoration:none">Author Information</a><div style="display:none" class="ui-widget" id="__NBK1268_ai__"><div class="contrib half_rhythm"><span itemprop="author">Fatma Ayhan</span>, BS<div class="affiliation small">Center for NeuroGenetics<br />Department of Molecular Genetics &#x00026; Microbiology<br />College of Medicine<br />University of Florida<br />Gainesville, Florida<div><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="ude.lfu@nahyaf" class="oemail">ude.lfu@nahyaf</a></div></div></div><div class="contrib half_rhythm"><span itemprop="author">Yoshio Ikeda</span>, MD, PhD<div class="affiliation small">Department of Neurology<br />Gunma University Graduate School of Medicine<br />Gunma, Japan<div><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="pj.ca.u-amnug@600adeki" class="oemail">pj.ca.u-amnug@600adeki</a></div></div></div><div class="contrib half_rhythm"><span itemprop="author">Joline C Dalton</span>, MS<div class="affiliation small">Department of Genetics, Cell Biology, and Development<br />University of Minnesota<br />Minneapolis, Minnesota<div><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="ude.nmu@notladcj" class="oemail">ude.nmu@notladcj</a></div></div></div><div class="contrib half_rhythm"><span itemprop="author">John W Day</span>, MD, PhD<div class="affiliation small">Department of Neurology<br />Stanford University<br />Palo Alto, California<div><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="ude.drofnats@yadwj" class="oemail">ude.drofnats@yadwj</a></div></div></div><div class="contrib half_rhythm"><span itemprop="author">Laura PW Ranum</span>, PhD<div class="affiliation small">Center for NeuroGenetics<br />Department of Molecular Genetics &#x00026; Microbiology<br />Department of Neurology<br />Genetics Institute<br />College of Medicine<br />University of Florida<br />Gainesville, Florida<div><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="ude.lfu@munar" class="oemail">ude.lfu@munar</a></div></div></div></div><p class="small">Initial Posting: <span itemprop="datePublished">November 27, 2001</span>; Last Update: <span itemprop="dateModified">April 3, 2014</span>.</p><p><em>Estimated reading time: 24 minutes</em></p></div><div class="jig-ncbiinpagenav body-content whole_rhythm" data-jigconfig="allHeadingLevels: ['h2'],smoothScroll: false" itemprop="text"><div id="sca8.Summary" itemprop="description"><h2 id="_sca8_Summary_">Summary</h2><div><h4 class="inline">Clinical characteristics.</h4><p>SCA8 is a slowly progressive ataxia with disease onset typically occurring in adulthood. Onset ranges from age one to 73 years. The progression is typically over decades regardless of the age of onset. Common initial symptoms are scanning dysarthria with a characteristic drawn-out slowness of speech and gait instability; life span is typically not shortened. Some individuals present with nystagmus, dysmetric saccades and, rarely, ophthalmoplegia. Tendon reflex hyperreflexity and extensor plantar responses are present in some severely <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals. Life span is typically not shortened.</p></div><div><h4 class="inline">Diagnosis/testing.</h4><p>The SCA8 <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> is caused by an expansion involving two overlapping genes, <i>ATXN8OS</i> and <i>ATXN8</i>.</p><p>The diagnosis of SCA8 is confirmed by the presence of a (CTG)<sub>n</sub> <a class="def" href="/books/n/gene/glossary/def-item/trinucleotide-repeat/">trinucleotide repeat</a> expansion in <i>ATXN8OS</i> (formerly known as <i>SCA8</i>). The pathogenic (CTG)<sub>n</sub> repeat is adjacent to a non-pathogenic but highly polymorphic, stably transmitted (CTA)<sub>n</sub> repeat, which makes it technically difficult to determine the precise number of pathogenic (CTG)<sub>n</sub> repeats. Therefore, the current reference ranges are based on the total number of both the (CTA)<sub>n</sub> and (CTG)<sub>n</sub> repeats. Normal alleles have 15 to 50 repeats. The repeat lengths most often associated with ataxia range from 80 to 250; however, repeat lengths ranging from 71 to more than 1300 have been found in some individuals with ataxia. Although reduced <a class="def" href="/books/n/gene/glossary/def-item/penetrance/">penetrance</a> is observed for alleles of all repeat lengths, it is most often observed with alleles of fewer than 100 repeats.</p><p>The pathogenesis of SCA8 also involves a (CAG)<sub>n</sub> repeat in <i>ATXN8</i>.</p></div><div><h4 class="inline">Management.</h4><p><i>Treatment of manifestations</i>: Canes and walkers to help prevent falls; modification of the home (e.g., grab bars, raised toilet seats, ramps for motorized chairs) as needed; speech therapy and communication devices for those with dysarthria; weighted eating utensils and dressing hooks to maintain some independence; feeding evaluations to reduce risk of aspiration from dysphagia; physical activity to maintain muscular and cardiopulmonary conditioning.</p><p><i>Prevention of secondary complications</i>: Vitamin supplements if caloric intake is reduced.</p><p><i>Surveillance</i>: Routine follow up with a neurologist.</p><p><i>Agents/circumstances to avoid</i>: Alcohol can exacerbate incoordination.</p><p><i>Other</i>: Tremor-controlling drugs do not work well.</p></div><div><h4 class="inline">Genetic counseling.</h4><p>The <i>ATXN8OS</i> (CTA)<sub>n</sub>(CTG)<sub>n</sub> composite repeat expansion is transmitted in an <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a> manner with reduced <a class="def" href="/books/n/gene/glossary/def-item/penetrance/">penetrance</a>. To date, all <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals whose parents have been evaluated with <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a> have one parent with an <i>ATXN8OS</i> (CTA)<sub>n</sub>(CTG)<sub>n</sub> expanded <a class="def" href="/books/n/gene/glossary/def-item/allele/">allele</a>; <a class="def" href="/books/n/gene/glossary/def-item/de-novo/"><i>de novo</i></a> expansion has not been reported. The (CTG)<sub>n</sub> component of the (CTA)<sub>n</sub>(CTG)<sub>n</sub> composite repeat is highly unstable and almost always expands on maternal transmission. When paternally transmitted, the (CTG)<sub>n</sub> repeat tract almost always contracts in length, usually to a length below 100 combined (CTA)<sub>n</sub>(CTG)<sub>n</sub> repeats. Each child of an individual with an <i>ATXN8OS</i> expanded allele has a 50% chance of inheriting the expanded allele. Although individuals with expansions of &#x0003e;50 combined repeats are at risk of developing ataxia sometime during their life span, the reduced penetrance of the disease means that the presence of an SCA8-related expansion cannot be used to predict whether offspring will ever develop symptoms of SCA8. Prenatal testing for pregnancies at 50% risk for SCA8 is possible.</p></div></div><div id="sca8.Diagnosis"><h2 id="_sca8_Diagnosis_">Diagnosis</h2><div id="sca8.Clinical_Diagnosis"><h3>Clinical Diagnosis</h3><p>SCA8 is suspected [<a class="bk_pop" href="#sca8.REF.day.2000.649">Day et al 2000</a>] in individuals with the following:</p><ul><li class="half_rhythm"><div class="half_rhythm">Principally cerebellar ataxia</div></li><li class="half_rhythm"><div class="half_rhythm">Slowly progressing ataxia</div></li><li class="half_rhythm"><div class="half_rhythm">Scanning dysarthria characterized by a drawn-out slowness of speech</div></li><li class="half_rhythm"><div class="half_rhythm">Marked truncal instability</div></li><li class="half_rhythm"><div class="half_rhythm">Hyperactive tendon reflexes</div></li><li class="half_rhythm"><div class="half_rhythm">Family history of ataxia consistent with single occurrence in the family or either an <a class="def" href="/books/n/gene/glossary/def-item/autosomal-recessive/">autosomal recessive</a> or <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a> pattern of inheritance.</div><div class="half_rhythm">Note: Because of the reduced <a class="def" href="/books/n/gene/glossary/def-item/penetrance/">penetrance</a>, a single occurrence in a family is the most common presentation of the disease.</div></li></ul><p>The spinocerebellar ataxias share many clinical symptoms in common and the diagnosis of SCA8 must be confirmed by <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a>.</p></div><div id="sca8.Molecular_Genetic_Testing"><h3>Molecular Genetic Testing</h3><p><b>Gene.</b> The expansion associated with the SCA8 <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> involves two overlapping genes, <i>ATXN8OS</i> and <i>ATXN8</i> [<a class="bk_pop" href="#sca8.REF.moseley.2006.758">Moseley et al 2006</a>]:</p><ul><li class="half_rhythm"><div>In the CTG direction, <i>ATXN8OS</i> (formerly known as <i>SCA8</i>) expresses transcripts containing the CUG expansion.</div></li><li class="half_rhythm"><div>In the CAG direction, <i>ATXN8</i> expresses the transcripts that encode a nearly pure polyglutamine expansion protein plus a polyalanine expansion protein expressed by repeat-associated non-ATG (RAN) translation [<a class="bk_pop" href="#sca8.REF.zu.2011.260">Zu et al 2011</a>].</div></li></ul><p>The expansion associated with the SCA8 <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> is located in both the 3' untranslated region of <i>ATXN8OS</i> and a short polyglutamine ORF in the more recently identified overlapping <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> <i>ATXN8</i> [<a class="bk_pop" href="#sca8.REF.moseley.2006.758">Moseley et al 2006</a>]. The CTG<b>&#x000b7;</b>CAG repeat is adjacent to a CTA<b>&#x000b7;</b>TAG repeat that is highly polymorphic but stable when transmitted from one generation to the next [<a class="bk_pop" href="#sca8.REF.koob.1999.379">Koob et al 1999</a>, <a class="bk_pop" href="#sca8.REF.moseley.2000c.2125">Moseley et al 2000c</a>].</p><p>The reduced <a class="def" href="/books/n/gene/glossary/def-item/penetrance/">penetrance</a> of CTG<b>&#x000b7;</b>CAG and the presence of the polymorphic CTA<b>&#x000b7;</b>TAG repeat have made it difficult to determine the pathogenic size range of the CTG<b>&#x000b7;</b>CAG repeat.</p><p><b>Allele sizes</b></p><ul><li class="half_rhythm"><div><b>Normal alleles:</b> 15 to 50 combined (CTA<b>&#x000b7;</b>TAG)<sub>n</sub>(CTG<b>&#x000b7;</b>CAG)<sub>n</sub> repeats</div></li><li class="half_rhythm"><div><b>Alleles of questionable significance:</b> It is not yet clear whether repeat sizes ranging from 50 to 70 repeats can be pathogenic.</div></li><li class="half_rhythm"><div><b>Reduced <a class="def" href="/books/n/gene/glossary/def-item/penetrance/">penetrance</a> <a class="def" href="/books/n/gene/glossary/def-item/allele/">allele</a> size:</b> Reduced penetrance is found for (CTA<b>&#x000b7;</b>TAG)<sub>n</sub>(CTG<b>&#x000b7;</b>CAG)<sub>n</sub> repeats of all sizes [<a class="bk_pop" href="#sca8.REF.ranum.1999.466">Ranum et al 1999</a>].</div></li><li class="half_rhythm"><div><b>Higher <a class="def" href="/books/n/gene/glossary/def-item/penetrance/">penetrance</a> <a class="def" href="/books/n/gene/glossary/def-item/allele/">allele</a> size:</b> 80 to 250 (CTA<b>&#x000b7;</b>TAG)<sub>n</sub>(CTG<b>&#x000b7;</b>CAG)<sub>n</sub> repeats are most often seen in individuals with ataxia; however, repeat sizes ranging from 71 to more than 1300 repeats have been found both in individuals who develop ataxia and in those who do not.</div></li></ul><p><b>Clinical testing</b></p><ul><li class="half_rhythm"><div><b>Targeted analysis for pathogenic variants.</b> Although it is the (CTG<b>&#x000b7;</b>CAG)<sub>n</sub> portion of the repeat tract that expands in <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals, the current method of detection measures (and the reference range is based on) the combined (CTA<b>&#x000b7;</b>TAG)<sub>n</sub>(CTG<b>&#x000b7;</b>CAG)<sub>n</sub> repeat total. For smaller <a class="def" href="/books/n/gene/glossary/def-item/allele/">allele</a> sizes (expansions &#x0003c;200 repeats), the <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> can be detected by <a class="def" href="/books/n/gene/glossary/def-item/pcr/">PCR</a>. For larger expansions (&#x0003e;200 combined (CTA<b>&#x000b7;</b>TAG)<sub>n</sub>(CTG<b>&#x000b7;</b>CAG)<sub>n</sub> CAG repeats), Southern analysis is needed to reliably detect expansions.</div></li></ul><div id="sca8.T.molecular_genetic_testing_used_in" class="table"><h3><span class="label">Table 1. </span></h3><div class="caption"><p>Molecular Genetic Testing Used in SCA8</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK1268/table/sca8.T.molecular_genetic_testing_used_in/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__sca8.T.molecular_genetic_testing_used_in_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_sca8.T.molecular_genetic_testing_used_in_1_1_1_1" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Genes&#x000a0;<sup>1</sup></th><th id="hd_h_sca8.T.molecular_genetic_testing_used_in_1_1_1_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Test Method</th><th id="hd_h_sca8.T.molecular_genetic_testing_used_in_1_1_1_3" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Proportion of Probands with a Pathogenic Variant Detectable by This Method</th></tr></thead><tbody><tr><td headers="hd_h_sca8.T.molecular_genetic_testing_used_in_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><i>ATXN8OS</i><br /><i>ATXN8</i></td><td headers="hd_h_sca8.T.molecular_genetic_testing_used_in_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Targeted analysis for pathogenic variants&#x000a0;<sup>2,&#x000a0;3</sup></td><td headers="hd_h_sca8.T.molecular_genetic_testing_used_in_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">~100%</td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt>1. </dt><dd><div id="sca8.TF.1.1"><p class="no_margin">See <a href="/books/NBK1268/#sca8.molgen.TA">Table A. Genes and Databases</a> for <a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> <a class="def" href="/books/n/gene/glossary/def-item/locus/">locus</a> and protein. See <a href="#sca8.Molecular_Genetics">Molecular Genetics</a> for information on pathogenic variants.</p></div></dd><dt>2. </dt><dd><div id="sca8.TF.1.2"><p class="no_margin">Pathogenic variants included in a panel may vary by laboratory.</p></div></dd><dt>3. </dt><dd><div id="sca8.TF.1.3"><p class="no_margin">Trinucleotide repeat expansion located within two overlapping genes: an untranslated portion of <i>ATXN8OS</i> and a short ORF for <i>ATXN8</i></p></div></dd></dl></div></div></div></div><div id="sca8.Testing_Strategy_To_ConfirmEstablis"><h3>Testing Strategy To Confirm/Establish the Diagnosis in a Proband</h3><p><b>Single-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> testing.</b> One strategy for molecular diagnosis of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> suspected of having SCA8 is analysis of <i>ATXN8OS</i>/<i>ATXN8</i>:</p><ul><li class="half_rhythm"><div><a class="def" href="/books/n/gene/glossary/def-item/pcr/">PCR</a> can be used as a first screen for an <i>ATXN8OS</i>/<i>ATXN8</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>. If a person has two normal alleles of different sizes, SCA8 can be ruled out. PCR can also detect small (&#x0003c;250-repeat) expansions.</div></li><li class="half_rhythm"><div>If <a class="def" href="/books/n/gene/glossary/def-item/pcr/">PCR</a> analysis fails to detect an expansion, and the PCR results indicate that the individual apparently has two alleles of the same size, Southern analysis should be performed to determine if an expansion that failed to be amplified by PCR is present.</div></li></ul><p><b>Multigene panel.</b> Another strategy for molecular diagnosis of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> suspected of having SCA8 is use of a <a class="def" href="/books/n/gene/glossary/def-item/multigene-panel/">multigene panel</a> that includes analysis of the other genes associated with disorders of similar <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> (see <a href="#sca8.Differential_Diagnosis">Differential Diagnosis</a>). Note: (1) The genes included in the panel and the diagnostic <a class="def" href="/books/n/gene/glossary/def-item/sensitivity/">sensitivity</a> of the testing used for each <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> vary by laboratory and are likely to change over time. (2) Some multigene panels may include genes not associated with the condition discussed in this <i>GeneReview</i>; thus, clinicians need to determine which multigene panel is most likely to identify the genetic cause of the condition at the most reasonable cost while limiting identification of variants of <a class="def" href="/books/n/gene/glossary/def-item/uncertain-significance/">uncertain significance</a> and pathogenic variants in genes that do not explain the underlying phenotype. (3) In some laboratories, panel options may include a custom laboratory-designed panel and/or custom phenotype-focused <a class="def" href="/books/n/gene/glossary/def-item/exome/">exome</a> analysis that includes genes specified by the clinician. (4) Methods used in a panel may include <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a>, <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a>, and/or other non-sequencing-based tests.</p><p>For an introduction to multigene panels click <a href="/books/n/gene/app5/#app5.Multigene_Panels">here</a>. More detailed information for clinicians ordering genetic tests can be found <a href="/books/n/gene/app5/#app5.Multigene_Panels_FAQs">here</a>.</p></div></div><div id="sca8.Clinical_Characteristics"><h2 id="_sca8_Clinical_Characteristics_">Clinical Characteristics</h2><div id="sca8.Clinical_Description"><h3>Clinical Description</h3><p>SCA8 is a slowly progressive ataxia with disease onset typically in adulthood. Onset has been reported from age one to 73 years [<a class="bk_pop" href="#sca8.REF.day.2000.649">Day et al 2000</a>, <a class="bk_pop" href="#sca8.REF.ikeda.2000a.950">Ikeda et al 2000a</a>, <a class="bk_pop" href="#sca8.REF.juvonen.2000.354">Juvonen et al 2000</a>, <a class="bk_pop" href="#sca8.REF.silveira.2000.830">Silveira et al 2000</a>, <a class="bk_pop" href="#sca8.REF.felling.2005.136">Felling &#x00026; Barron 2005</a>, <a class="bk_pop" href="#sca8.REF.maschke.2005.1405">Maschke et al 2005</a>]. The progression is typically over decades regardless of the age of onset. Common initial symptoms reported are dysarthria and gait instability; life span is typically not shortened [<a class="bk_pop" href="#sca8.REF.day.2000.649">Day et al 2000</a>, <a class="bk_pop" href="#sca8.REF.juvonen.2000.354">Juvonen et al 2000</a>].</p><p>Clinical symptoms observed in most individuals with the SCA8 form of ataxia are dysarthria and clumsiness of gait and limb movements [<a class="bk_pop" href="#sca8.REF.day.2000.649">Day et al 2000</a>, <a class="bk_pop" href="#sca8.REF.ikeda.2000a.950">Ikeda et al 2000a</a>, <a class="bk_pop" href="#sca8.REF.juvonen.2000.354">Juvonen et al 2000</a>, <a class="bk_pop" href="#sca8.REF.cellini.2001.1856">Cellini et al 2001</a>, <a class="bk_pop" href="#sca8.REF.brusco.2002.923">Brusco et al 2002</a>, <a class="bk_pop" href="#sca8.REF.taz_n.2002.404">Taz&#x000f3;n et al 2002</a>, <a class="bk_pop" href="#sca8.REF.topisirovic.2002.321">Topisirovic et al 2002</a>, <a class="bk_pop" href="#sca8.REF.mosemiller.2003.175">Mosemiller et al 2003</a>, <a class="bk_pop" href="#sca8.REF.sch_ls.2003.110">Sch&#x000f6;ls et al 2003</a>, <a class="bk_pop" href="#sca8.REF.zeman.2004.459">Zeman et al 2004</a>, <a class="bk_pop" href="#sca8.REF.lilja.2005.31">Lilja et al 2005</a>]. One distinguishing feature of SCA8 is scanning dysarthria with a characteristic drawn-out slowness of speech. At an early stage, speech can be disproportionately <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> relative to other cerebellar signs. Ataxic symptoms of the lower extremities appear to be more pronounced than those of upper extremities. Severe truncal titubation that advances with disease progression is characteristic. Some individuals with SCA8 present with nystagmus, dysmetric saccades and, rarely, ophthalmoplegia. Tendon reflex hyperactivity and extensor plantar responses are present in some severely affected individuals [<a class="bk_pop" href="#sca8.REF.day.2000.649">Day et al 2000</a>, <a class="bk_pop" href="#sca8.REF.ikeda.2000a.950">Ikeda et al 2000a</a>, <a class="bk_pop" href="#sca8.REF.juvonen.2000.354">Juvonen et al 2000</a>].</p><p>Cognitive impairment, found in 40% of <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals of Finnish heritage, has not been observed in other populations [<a class="bk_pop" href="#sca8.REF.juvonen.2000.354">Juvonen et al 2000</a>, <a class="bk_pop" href="#sca8.REF.stone.2001.229">Stone et al 2001</a>, <a class="bk_pop" href="#sca8.REF.zeman.2004.459">Zeman et al 2004</a>, <a class="bk_pop" href="#sca8.REF.baba.2005.147">Baba et al 2005</a>, <a class="bk_pop" href="#sca8.REF.lilja.2005.31">Lilja et al 2005</a>].</p><p>Atypical clinical features identified in individuals <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> for an <i>ATXN8OS</i>/<i>ATXN8</i> expansion include parkinsonism, multiple-system atrophy, severe childhood onset, oramandibular dystonia, dysphagia, respiratory muscle weakness, seizure-like episodes [<a class="bk_pop" href="#sca8.REF.baba.2005.147">Baba et al 2005</a>, <a class="bk_pop" href="#sca8.REF.factor.2005.462">Factor et al 2005</a>, <a class="bk_pop" href="#sca8.REF.felling.2005.136">Felling &#x00026; Barron 2005</a>, <a class="bk_pop" href="#sca8.REF.munhoz.2006.191">Munhoz et al 2006</a>, <a class="bk_pop" href="#sca8.REF.gupta.2009.621">Gupta &#x00026; Jankovic 2009</a>, <a class="bk_pop" href="#sca8.REF.ushe.2012.1741">Ushe &#x00026; Perlmutter 2012</a>, <a class="bk_pop" href="#sca8.REF.kim.2013.274">Kim et al 2013</a>]. The causative relationship between the <i>ATXN8OS</i>/<i>ATXN8</i> expansion and these other conditions remains unknown, given the relatively high frequency of the <i>ATXN8OS</i>/<i>ATXN8</i> expansion in the general population and the reduced <a class="def" href="/books/n/gene/glossary/def-item/penetrance/">penetrance</a> of the disease.</p><p><b>Neuroimaging.</b> MRI and CT have consistently shown cerebellar atrophy, specifically in the cerebellar hemisphere and vermis in individuals with SCA8 [<a class="bk_pop" href="#sca8.REF.day.2000.649">Day et al 2000</a>, <a class="bk_pop" href="#sca8.REF.ikeda.2000a.950">Ikeda et al 2000a</a>, <a class="bk_pop" href="#sca8.REF.juvonen.2000.354">Juvonen et al 2000</a>, <a class="bk_pop" href="#sca8.REF.cellini.2001.1856">Cellini et al 2001</a>, <a class="bk_pop" href="#sca8.REF.brusco.2002.923">Brusco et al 2002</a>, <a class="bk_pop" href="#sca8.REF.taz_n.2002.404">Taz&#x000f3;n et al 2002</a>, <a class="bk_pop" href="#sca8.REF.topisirovic.2002.321">Topisirovic et al 2002</a>, <a class="bk_pop" href="#sca8.REF.sch_ls.2003.110">Sch&#x000f6;ls et al 2003</a>, <a class="bk_pop" href="#sca8.REF.zeman.2004.459">Zeman et al 2004</a>, <a class="bk_pop" href="#sca8.REF.lilja.2005.31">Lilja et al 2005</a>]. In one individual in whom serial MRI scans were performed nine years apart, little progression was seen in the cerebellar atrophy [<a class="bk_pop" href="#sca8.REF.day.2000.649">Day et al 2000</a>]. Mild cerebellar atrophy was observed in an asymptomatic male age 71 years with an <i>ATXN8OS</i>/<i>ATXN8</i> expansion [<a class="bk_pop" href="#sca8.REF.ikeda.2000b.76">Ikeda et al 2000b</a>].</p></div><div id="sca8.GenotypePhenotype_Correlations"><h3>Genotype-Phenotype Correlations</h3><p>Although there is a correlation between repeat number and <a class="def" href="/books/n/gene/glossary/def-item/penetrance/">penetrance</a> in some families [<a class="bk_pop" href="#sca8.REF.koob.1999.379">Koob et al 1999</a>, <a class="bk_pop" href="#sca8.REF.day.2000.649">Day et al 2000</a>], longer alleles in the size range from 50 to 250 CTA/CTG repeats are more often found in <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals than in unaffected relatives (p&#x0003c;0.001).</p><p>No correlation between the size of the expansion and age of onset or disease severity was observed [<a class="bk_pop" href="#sca8.REF.day.2000.649">Day et al 2000</a>, <a class="bk_pop" href="#sca8.REF.ikeda.2000a.950">Ikeda et al 2000a</a>, <a class="bk_pop" href="#sca8.REF.juvonen.2000.354">Juvonen et al 2000</a>].</p><p>The clinical presentation in the two individuals from the MN-A family <a class="def" href="/books/n/gene/glossary/def-item/homozygous/">homozygous</a> for the <i>ATXN8OS</i>/<i>ATXN8</i> expansion did not differ in severity from the clinical presentation in sibs <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> for the <i>ATXN8OS</i>/<i>ATXN8</i> expansion [<a class="bk_pop" href="#sca8.REF.day.2000.649">Day et al 2000</a>].</p><p>Individuals <a class="def" href="/books/n/gene/glossary/def-item/homozygous/">homozygous</a> for the <i>ATXN8OS</i>/<i>ATXN8</i> expansion have been reported more frequently than for other forms of spinocerebellar ataxia caused by similar expansions [<a class="bk_pop" href="#sca8.REF.koob.1999.379">Koob et al 1999</a>, <a class="bk_pop" href="#sca8.REF.day.2000.649">Day et al 2000</a>, <a class="bk_pop" href="#sca8.REF.stevanin.2000.213">Stevanin et al 2000</a>, <a class="bk_pop" href="#sca8.REF.taz_n.2002.404">Taz&#x000f3;n et al 2002</a>, <a class="bk_pop" href="#sca8.REF.izumi.2003.704">Izumi et al 2003</a>, <a class="bk_pop" href="#sca8.REF.sch_ls.2003.110">Sch&#x000f6;ls et al 2003</a>, <a class="bk_pop" href="#sca8.REF.brusco.2004.727">Brusco et al 2004</a>, <a class="bk_pop" href="#sca8.REF.corral.2005.549">Corral et al 2005</a>, <a class="bk_pop" href="#sca8.REF.juvonen.2005.154">Juvonen et al 2005</a>]. The ages at onset in most individuals homozygous for an <i>ATXN8OS</i>/<i>ATXN8</i> expansion were not obviously accelerated compared to the ages of onset of individuals <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> for an <i>ATXN8OS</i>/<i>ATXN8</i> expansion.</p></div><div id="sca8.Penetrance"><h3>Penetrance</h3><p>In the large family (MN-A) originally reported to have SCA8 (Lod 6.8 at &#x003f4;:0.00), <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals have longer CTG<b>&#x000b7;</b>CAG repeat tracts (mean: 117) than the 21 asymptomatic individuals with a CTG<b>&#x000b7;</b>CAG repeat expansion (mean: 92; p&#x0003c;10<sup>-6</sup>). These results indicate that repeat length plays a role in disease <a class="def" href="/books/n/gene/glossary/def-item/penetrance/">penetrance</a> [<a class="bk_pop" href="#sca8.REF.koob.1999.379">Koob et al 1999</a>, <a class="bk_pop" href="#sca8.REF.day.2000.649">Day et al 2000</a>]. Further analysis of other families showed that the pathogenic range can vary among families and that a positive test for an <i>ATXN8OS</i>/<i>ATXN8</i> expansion, regardless of the repeat size, cannot be used to predict whether an asymptomatic individual will develop ataxia [<a class="bk_pop" href="#sca8.REF.ranum.1999.466">Ranum et al 1999</a>, <a class="bk_pop" href="#sca8.REF.moseley.2000c.2125">Moseley et al 2000c</a>, <a class="bk_pop" href="#sca8.REF.worth.2000.214">Worth et al 2000</a>, <a class="bk_pop" href="#sca8.REF.ikeda.2004.3">Ikeda et al 2004</a>].</p><p>The molecular basis for the reduced <a class="def" href="/books/n/gene/glossary/def-item/penetrance/">penetrance</a> is not yet fully understood; however, the following features of SCA8 may play a role in reduced penetrance.</p><ul><li class="half_rhythm"><div><b>The polymorphic CTA&#x000b7;TAG repeat.</b> The CTA<b>&#x000b7;</b>TAG repeat, which is adjacent to the CTG<b>&#x000b7;</b>CAG repeat, remains stable during transmission; however, the CTA<b>&#x000b7;</b>TAG repeat varies among families, ranging in size from one to 21 repeats [<a class="bk_pop" href="#sca8.REF.koob.1999.379">Koob et al 1999</a>, <a class="bk_pop" href="#sca8.REF.moseley.2000c.2125">Moseley et al 2000c</a>, <a class="bk_pop" href="#sca8.REF.stevanin.2000.213">Stevanin et al 2000</a>]. Because the <a class="def" href="/books/n/gene/glossary/def-item/pcr/">PCR</a> assay measures the length of both repeats, the polymorphic CTA<b>&#x000b7;</b>TAG may account for some of the apparent interfamilial differences in <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> <a class="def" href="/books/n/gene/glossary/def-item/allele/">allele</a> size ranges and reduced <a class="def" href="/books/n/gene/glossary/def-item/penetrance/">penetrance</a> of the <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>.</div></li><li class="half_rhythm"><div><b>Interruptions within the CTG&#x000b7;CAG expansion.</b> Interruptions within the CTG<b>&#x000b7;</b>CAG expansion by one or more CCG<b>&#x000b7;</b>CGG, CTA<b>&#x000b7;</b>TAG, CTC<b>&#x000b7;</b>GAG, CCA<b>&#x000b7;</b>TGG, or CTT<b>&#x000b7;</b>AAG trinucleotides have also been observed in full-<a class="def" href="/books/n/gene/glossary/def-item/penetrance/">penetrance</a> alleles [<a class="bk_pop" href="#sca8.REF.moseley.2000c.2125">Moseley et al 2000c</a>]. Surprisingly, these interruptions can duplicate when transmitted from one generation to the next. Individuals with the SCA8 form of ataxia have been shown to have both pure CTG<b>&#x000b7;</b>CAG tracts and tracts with interruptions. Most normal-length alleles do not have interrupted CTG<b>&#x000b7;</b>CAG repeat tracts, although one normal <a class="def" href="/books/n/gene/glossary/def-item/allele/">allele</a> (23 combined repeats) with an interruption in the CTG<b>&#x000b7;</b>CAG portion of the repeat tract has been reported [<a class="bk_pop" href="#sca8.REF.sobrido.2001.1310">Sobrido et al 2001</a>]. The potential influence of the interruptions on the development of ataxia is not yet clear [<a class="bk_pop" href="#sca8.REF.moseley.2000c.2125">Moseley et al 2000c</a>, <a class="bk_pop" href="#sca8.REF.mosemiller.2003.175">Mosemiller et al 2003</a>].</div></li><li class="half_rhythm"><div><b>Intergenerational size changes.</b> The <i>ATXN8OS</i>/<i>ATXN8</i> expansion is unstable and almost always changes in size when transmitted from generation to generation. A maternal <a class="def" href="/books/n/gene/glossary/def-item/penetrance/">penetrance</a> bias for disease transmission that occurs in some families appears to be related to the maternal expansion bias of the CTG<b>&#x000b7;</b>CAG repeat tract (-11 to +900) [<a class="bk_pop" href="#sca8.REF.koob.1999.379">Koob et al 1999</a>, <a class="bk_pop" href="#sca8.REF.ranum.1999.466">Ranum et al 1999</a>, <a class="bk_pop" href="#sca8.REF.day.2000.649">Day et al 2000</a>, <a class="bk_pop" href="#sca8.REF.corral.2005.549">Corral et al 2005</a>]. In contrast, a bias for contraction (-86 to +7) of the CTG<b>&#x000b7;</b>CAG repeat is observed with paternal transmission [<a class="bk_pop" href="#sca8.REF.koob.1999.379">Koob et al 1999</a>, <a class="bk_pop" href="#sca8.REF.ranum.1999.466">Ranum et al 1999</a>]. In sperm from males with SCA8, nearly all of the expanded alleles contract, resulting in tracts that usually contain fewer than 100 combined repeats [<a class="bk_pop" href="#sca8.REF.moseley.2000c.2125">Moseley et al 2000c</a>]. It is likely that these dramatic repeat contractions in sperm play a role in the reduced penetrance of paternal transmissions. In summary, intergenerational changes in repeat size appear to play a role in the reduced penetrance of SCA8, with ataxia more likely to result from the larger maternally transmitted repeat tracts than from smaller paternally transmitted expansions.</div></li></ul></div><div id="sca8.Anticipation"><h3>Anticipation</h3><p><b>Maternal transmission.</b> The CTG<b>&#x000b7;</b>CAG expansion is more likely to become larger when maternally transmitted. Therefore, individuals who inherit the expansion from their mothers may be at a greater risk of developing ataxia because their <a class="def" href="/books/n/gene/glossary/def-item/allele/">allele</a> sizes tend to be larger and, at least in some families, in a more penetrant size range. It should be pointed out, however, that all expansion sizes show reduced <a class="def" href="/books/n/gene/glossary/def-item/penetrance/">penetrance</a>; thus, repeat length cannot be used to predict whether an individual will or will not develop disease.</p><p><b>Paternal transmission.</b> The CTG<b>&#x000b7;</b>CAG expansion is more likely to contract with paternal transmission, usually resulting in smaller alleles that may fall into less penetrant size ranges. Therefore, individuals who inherit the expansion from their fathers, at least in some families, are at a lower risk of developing ataxia. However, all expansion sizes show reduced <a class="def" href="/books/n/gene/glossary/def-item/penetrance/">penetrance</a>; thus, repeat length cannot be used to predict whether an individual will or will not develop disease.</p></div><div id="sca8.Prevalence"><h3>Prevalence</h3><p>Epidemiologic studies of the frequency of the <i>ATXN8OS</i>/<i>ATXN8</i> expansion have not been performed, but estimates of the prevalence of <i>ATXN8OS</i>/<i>ATXN8</i> expansions in various control groups suggest that the prevalence of <i>ATXN8OS</i>/<i>ATXN8</i> expansions larger than 50 combined repeats ranges from approximately 1:100 to 1:1200 chromosomes in various ethnic populations [<a class="bk_pop" href="#sca8.REF.koob.1999.379">Koob et al 1999</a>, <a class="bk_pop" href="#sca8.REF.ikeda.2000a.950">Ikeda et al 2000a</a>, <a class="bk_pop" href="#sca8.REF.juvonen.2000.354">Juvonen et al 2000</a>, <a class="bk_pop" href="#sca8.REF.vincent.2000a.819">Vincent et al 2000a</a>, <a class="bk_pop" href="#sca8.REF.su_ek.2004.101">Su&#x00142;ek et al 2004</a>, <a class="bk_pop" href="#sca8.REF.zeman.2004.459">Zeman et al 2004</a>]. (See <a href="#sca8.Molecular_Genetics">Molecular Genetics</a>).</p><p>The prevalence of the expansion and the SCA8 form of ataxia may be especially common in Finland [<a class="bk_pop" href="#sca8.REF.juvonen.2000.354">Juvonen et al 2000</a>, <a class="bk_pop" href="#sca8.REF.juvonen.2005.154">Juvonen et al 2005</a>].</p><p>The SCA8 form of ataxia is thought to account for 2%-5% of <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a> forms of inherited ataxia. The prevalence of the disease is far lower than the prevalence of abnormal <i>ATXN8OS</i>/<i>ATXN8</i> expansions because of the reduced <a class="def" href="/books/n/gene/glossary/def-item/penetrance/">penetrance</a> of the expanded <a class="def" href="/books/n/gene/glossary/def-item/allele/">allele</a>. Most of the expansions found in control groups are either in repeat ranges that are less penetrant or at the lower end of the expansion range (50-100 combined repeats), or are very large expansions (&#x0003e;500 repeats) [<a class="bk_pop" href="#sca8.REF.ikeda.2004.3">Ikeda et al 2004</a>].</p></div></div><div id="sca8.Genetically_Related_Allelic_Disorde"><h2 id="_sca8_Genetically_Related_Allelic_Disorde_">Genetically Related (Allelic) Disorders</h2><p>No phenotypes other than those discussed in this <i>GeneReview</i> have been shown to be associated with pathogenic variants in <i>ATXN8OS</i> or <i>ATXN8</i>.</p></div><div id="sca8.Differential_Diagnosis"><h2 id="_sca8_Differential_Diagnosis_">Differential Diagnosis</h2><p><b>Ataxia.</b> SCA8 is similar to other SCAs in that it affects coordination, with oculomotor and bulbar involvement and limb and gait ataxia (see <a href="/books/n/gene/ataxias/">Ataxia Overview</a>). Some distinctions exist between SCA8 and other SCAs:</p><ul><li class="half_rhythm"><div><a href="/books/n/gene/sca1/"><b>SCA1</b></a><b>.</b> SCA8 disease progression is much slower, with less bulbar involvement than SCA1 [<a class="bk_pop" href="#sca8.REF.schut.1950.535">Schut 1950</a>, <a class="bk_pop" href="#sca8.REF.day.2000.649">Day et al 2000</a>].</div></li><li class="half_rhythm"><div><a href="/books/n/gene/sca2/"><b>SCA2</b></a><b>.</b> Saccadic eye movements in SCA8 are not dramatically slowed, in contrast to SCA2 [<a class="bk_pop" href="#sca8.REF.orozco_diaz.1990.1369">Orozco Diaz et al 1990</a>].</div></li><li class="half_rhythm"><div><a href="/books/n/gene/sca3/"><b>SCA3</b></a><b>.</b> Unlike SCA3, SCA8 does not show marked signs or symptoms suggestive of involvement of either lower motor neurons or extrapyramidal neurons [<a class="bk_pop" href="#sca8.REF.barbeau.1984.510">Barbeau et al 1984</a>].</div></li><li class="half_rhythm"><div><b>SCA4.</b> Although sensory nerves are <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a>, SCA8 does not result in the complete loss of sensory nerve function seen in SCA4 [<a class="bk_pop" href="#sca8.REF.flanigan.1996.392">Flanigan et al 1996</a>].</div></li><li class="half_rhythm"><div><b>SCA5,</b>
<a href="/books/n/gene/sca6/"><b>SCA6</b></a><b>.</b> In contrast to the mainly cerebellar presentations of SCA5 and SCA6, severely <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals with SCA8 have spastic dysarthria, tendon reflex hyperactivity, and extensor plantar responses [<a class="bk_pop" href="#sca8.REF.ranum.1994.280">Ranum et al 1994</a>, <a class="bk_pop" href="#sca8.REF.zhuchenko.1997.62">Zhuchenko et al 1997</a>].</div></li><li class="half_rhythm"><div><a href="/books/n/gene/sca7/"><b>SCA7</b></a><b>.</b> Unlike SCA7, SCA8 does not feature retinal degeneration [<a class="bk_pop" href="#sca8.REF.gouw.1995.89">Gouw et al 1995</a>].</div></li><li class="half_rhythm"><div><a href="/books/n/gene/sca10/"><b>SCA10</b></a><b>.</b> Seizures are not common in individuals with SCA8, distinguishing it from SCA10 [<a class="bk_pop" href="#sca8.REF.matsuura.2000.191">Matsuura et al 2000</a>].</div></li><li class="half_rhythm"><div><b>SCA12.</b> While cognitive decline has been reported in some families with SCA8 [<a class="bk_pop" href="#sca8.REF.zeman.2004.459">Zeman et al 2004</a>, <a class="bk_pop" href="#sca8.REF.baba.2005.147">Baba et al 2005</a>, <a class="bk_pop" href="#sca8.REF.lilja.2005.31">Lilja et al 2005</a>], it occurs less commonly than in SCA12 [<a class="bk_pop" href="#sca8.REF.rasmussen.2001.234">Rasmussen et al 2001</a>].</div></li></ul><p><b>Psychiatric symptoms.</b> The <i>ATXN8OS</i>/<i>ATXN8</i> expansion has been found in individuals with psychiatric conditions, as well as various control populations [<a class="bk_pop" href="#sca8.REF.pato.2000.854">Pato et al 2000</a>, <a class="bk_pop" href="#sca8.REF.vincent.2000a.819">Vincent et al 2000a</a>, <a class="bk_pop" href="#sca8.REF.vincent.2000b.873">Vincent et al 2000b</a>]. The frequency of <i>ATXN8OS</i>/<i>ATXN8</i> expansions is not significantly higher among individuals under psychiatric care than in controls and therefore the <i>ATXN8OS</i>/<i>ATXN8</i> expansion is unlikely to play a role in psychiatric disorders.</p></div><div id="sca8.Management"><h2 id="_sca8_Management_">Management</h2><div id="sca8.Evaluations_Following_Initial_Diagn"><h3>Evaluations Following Initial Diagnosis</h3><p>To establish the extent of disease and needs in an individual diagnosed with spinocerebellar ataxia type 8 (SCA8), the following evaluations are recommended:</p><ul><li class="half_rhythm"><div>Neurologic assessment, including neuroimaging (brain MRI or CT)</div></li><li class="half_rhythm"><div>Assessment of the family <a class="def" href="/books/n/gene/glossary/def-item/pedigree/">pedigree</a> and the disease course in other <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> family members to aid in establishing a clinical prognosis</div></li><li class="half_rhythm"><div>Consultation with a clinical geneticist and/or genetic counselor</div></li></ul></div><div id="sca8.Treatment_of_Manifestations"><h3>Treatment of Manifestations</h3><p>Use of canes and walkers helps prevent falls.</p><p>Modification of the home with such conveniences as grab bars, raised toilet seats, and ramps to accommodate motorized chairs may be necessary.</p><p>Speech therapy, communication devices such as writing pads, and computer-based devices may benefit those with dysarthria.</p><p>Weighted eating utensils and dressing hooks help maintain some degree of independence.</p><p>When dysphagia becomes troublesome, a video esophagram can identify the consistency of food least likely to trigger aspiration.</p><p>Although neither exercise nor physical therapy has been shown to stem the progression of incoordination, individuals with SCA8 should try to remain active in order to maintain their muscular and cardiopulmonary conditioning.</p><p>Weight control is important because obesity can exacerbate difficulties with ambulation and mobility.</p></div><div id="sca8.Prevention_of_Primary_Manifestation"><h3>Prevention of Primary Manifestations</h3><p>Management of <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals remains supportive, as there is no known therapy to delay or halt the progression of the disease.</p></div><div id="sca8.Prevention_of_Secondary_Complicatio"><h3>Prevention of Secondary Complications</h3><p>No dietary factor has been shown to curtail symptoms; however, vitamin supplements are recommended, particularly if caloric intake is reduced.</p></div><div id="sca8.Surveillance"><h3>Surveillance</h3><p>Affected individuals should regularly visit a neurologist familiar with the ataxia syndromes to identify potential complications that develop over time and to manage clinical challenges associated with decreased mobility and exercise or difficulties with speech and swallowing.</p></div><div id="sca8.AgentsCircumstances_to_Avoid"><h3>Agents/Circumstances to Avoid</h3><p>Alcohol should be avoided because it can exacerbate problems with incoordination.</p><p>Affected individuals should get plenty of rest; symptoms are often aggravated by fatigue.</p></div><div id="sca8.Evaluation_of_Relatives_at_Risk"><h3>Evaluation of Relatives at Risk</h3><p>See <a href="#sca8.Related_Genetic_Counseling_Issues">Genetic Counseling</a> for issues related to testing of at-risk relatives for <a class="def" href="/books/n/gene/glossary/def-item/genetic-counseling/">genetic counseling</a> purposes.</p></div><div id="sca8.Therapies_Under_Investigation"><h3>Therapies Under Investigation</h3><p>Search <a href="http://clinicaltrials.gov/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">ClinicalTrials.gov</a> in the US and <a href="http://www.ClinicalTrialsRegister.eu" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.ClinicalTrialsRegister.eu</a> in Europe for access to information on clinical studies for a wide range of diseases and conditions. Note: There may not be clinical trials for this disorder.</p></div><div id="sca8.Other"><h3>Other</h3><p>Tremor-controlling drugs do not work well for cerebellar tremors.</p></div></div><div id="sca8.Genetic_Counseling"><h2 id="_sca8_Genetic_Counseling_">Genetic Counseling</h2><p>
<i>Genetic counseling is the process of providing individuals and families with
information on the nature, inheritance, and implications of genetic disorders to help them
make informed medical and personal decisions. The following section deals with genetic
risk assessment and the use of family history and genetic testing to clarify genetic
status for family members. This section is not meant to address all personal, cultural, or
ethical issues that individuals may face or to substitute for consultation with a genetics
professional</i>. &#x02014;ED.</p><div id="sca8.Mode_of_Inheritance"><h3>Mode of Inheritance</h3><p>The <i>ATXN8OS</i>/<i>ATXN8</i> repeat expansion is transmitted in an <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a> manner with reduced <a class="def" href="/books/n/gene/glossary/def-item/penetrance/">penetrance</a>.</p></div><div id="sca8.Risk_to_Family_Members"><h3>Risk to Family Members</h3><p><b>Parents of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a></b></p><ul><li class="half_rhythm"><div>To date, all probands whose parents have been evaluated with <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a> have one parent with an <i>ATXN8OS</i>/<i>ATXN8</i> expanded <a class="def" href="/books/n/gene/glossary/def-item/allele/">allele</a>.</div></li><li class="half_rhythm"><div>The parent may or may not show symptoms of ataxia depending on the size of the expansion and other factors that affect the <a class="def" href="/books/n/gene/glossary/def-item/penetrance/">penetrance</a> of the expanded <a class="def" href="/books/n/gene/glossary/def-item/allele/">allele</a> [<a class="bk_pop" href="#sca8.REF.koob.1999.379">Koob et al 1999</a>, <a class="bk_pop" href="#sca8.REF.day.2000.649">Day et al 2000</a>]. Differences in intergenerational instability may play a role in reduced penetrance [<a class="bk_pop" href="#sca8.REF.koob.1999.379">Koob et al 1999</a>, <a class="bk_pop" href="#sca8.REF.day.2000.649">Day et al 2000</a>, <a class="bk_pop" href="#sca8.REF.moseley.2000c.2125">Moseley et al 2000c</a>].</div></li><li class="half_rhythm"><div>Probands with a <a class="def" href="/books/n/gene/glossary/def-item/de-novo/"><i>de novo</i></a> expansion have not been reported.</div></li><li class="half_rhythm"><div>Recommendations for the evaluation of parents of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> with an apparent <a class="def" href="/books/n/gene/glossary/def-item/de-novo/"><i>de novo</i></a> expansion include <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a>.</div></li></ul><p>Note: In the absence of <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a>, the family history may appear to be negative because of failure to recognize the disorder in family members, early death of the parent before the onset of symptoms, reduced <a class="def" href="/books/n/gene/glossary/def-item/penetrance/">penetrance</a>, or late onset of the disease in the <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> parent; however, all individuals diagnosed with SCA8 have a parent with an <i>ATXN8OS</i>/<i>ATXN8</i> expanded <a class="def" href="/books/n/gene/glossary/def-item/allele/">allele</a>.</p><p><b>Mother of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a></b></p><ul><li class="half_rhythm"><div>The <i>ATXN8OS</i>/<i>ATXN8</i> CTG<b>&#x000b7;</b>CAG expanded <a class="def" href="/books/n/gene/glossary/def-item/allele/">allele</a> is highly unstable and almost always expands on maternal transmission.</div></li><li class="half_rhythm"><div>In one family (the MN-A family), a maternal <a class="def" href="/books/n/gene/glossary/def-item/penetrance/">penetrance</a> bias was found in which asymptomatic mothers with shorter repeat sizes had <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> children with longer repeat tracts [<a class="bk_pop" href="#sca8.REF.day.2000.649">Day et al 2000</a>]. However, additional families with SCA8 have not shown a maternal bias for transmission; in these families, both paternal and maternal transmission can result in affected and unaffected offspring.</div></li></ul><p><b>Father of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a></b></p><ul><li class="half_rhythm"><div>When paternally transmitted, the <i>ATXN8OS</i>/<i>ATXN8</i> (CTG<b>&#x000b7;</b>CAG)<sub>n</sub> repeat tract almost always contracts in length, usually to size ranges close to or below 100 (CTA<b>&#x000b7;</b>TAG)<sub>n</sub>(CTG<b>&#x000b7;</b>CAG)<sub>n</sub> repeats, <a class="def" href="/books/n/gene/glossary/def-item/allele/">allele</a> lengths that in some families are less often associated with ataxia.</div></li><li class="half_rhythm"><div>Individuals <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> by SCA8 can inherit the expanded <a class="def" href="/books/n/gene/glossary/def-item/allele/">allele</a> from either parent.</div></li></ul><p><b>Sibs of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a></b></p><ul><li class="half_rhythm"><div>The risk to the sibs of the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> depends on the genetic status of the parents.</div></li><li class="half_rhythm"><div>Sibs of an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individual have a 50% chance of inheriting the expanded (CTA<b>&#x000b7;</b>TAG)<sub>n</sub>(CTG<b>&#x000b7;</b>CAG)<sub>n</sub>
<i>ATXN8OS</i>/<i>ATXN8</i> <a class="def" href="/books/n/gene/glossary/def-item/allele/">allele</a> if one parent has an expansion.</div></li><li class="half_rhythm"><div>Neither family history nor the composite (CTA<b>&#x000b7;</b>TAG)<sub>n</sub>(CTG<b>&#x000b7;</b>CAG)<sub>n</sub> repeat length can accurately predict whether a sib will develop the disease or what the age of onset, severity, symptoms, or progression of the disease will be.</div></li></ul><p><b>Offspring of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a></b></p><ul><li class="half_rhythm"><div>Each child of an individual with an <i>ATXN8OS</i>/<i>ATXN8</i> expanded <a class="def" href="/books/n/gene/glossary/def-item/allele/">allele</a> has a 50% chance of inheriting that <i>ATXN8OS</i>/<i>ATXN8</i> allele.</div></li><li class="half_rhythm"><div>Although the risk of developing ataxia is dependent on the size of the expansion and probably also on other factors that affect the <a class="def" href="/books/n/gene/glossary/def-item/penetrance/">penetrance</a> of the expanded <a class="def" href="/books/n/gene/glossary/def-item/allele/">allele</a>, neither family history nor the combined (CTA<b>&#x000b7;</b>TAG)<sub>n</sub>(CTG<b>&#x000b7;</b>CAG)<sub>n</sub> repeat size can be used to accurately predict which offspring will develop symptoms of the disease. The length of the repeat tract does not correlate with the age of onset, severity, symptoms, or progression of the disease.</div><ul><li class="half_rhythm"><div><b>Maternal transmission.</b> The CTG<b>&#x000b7;</b>CAG expansion is more likely to become larger when maternally transmitted. In some families, individuals who inherit the expanded <a class="def" href="/books/n/gene/glossary/def-item/allele/">allele</a> from their mothers are at a greater risk of developing ataxia, because their allele sizes tend to be large and thus in a more penetrant size range.</div></li><li class="half_rhythm"><div><b>Paternal transmission.</b> The CTG<b>&#x000b7;</b>CAG expansion is more likely to contract with paternal transmission, usually resulting in smaller <a class="def" href="/books/n/gene/glossary/def-item/allele/">allele</a> sizes, which in some families are less penetrant. Therefore, in some families, individuals who inherit the expanded allele from their father are at a lower risk of developing ataxia.</div></li></ul></li></ul><p><b>Other family members of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a></b></p><ul><li class="half_rhythm"><div>The risk to other family members depends on the genetic status of the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>'s parents.</div></li><li class="half_rhythm"><div>If a parent is <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> and/or has the CTG<b>&#x000b7;</b>CAG expanded <a class="def" href="/books/n/gene/glossary/def-item/allele/">allele</a>, his or her family members are at risk.</div></li></ul></div><div id="sca8.Related_Genetic_Counseling_Issues"><h3>Related Genetic Counseling Issues</h3><p><b>Considerations in families with an apparent <a class="def" href="/books/n/gene/glossary/def-item/de-novo/"><i>de novo</i></a> expansion.</b> When neither parent of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> with an <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a> condition has the pathogenic expansion, it is likely that the proband has a <i>de novo</i> expansion. However, possible non-medical explanations including <a class="def" href="/books/n/gene/glossary/def-item/alternate-paternity/">alternate paternity</a> or maternity (e.g., with assisted reproduction) or undisclosed adoption could also be explored.</p><p><b>Reduced <a class="def" href="/books/n/gene/glossary/def-item/penetrance/">penetrance</a>.</b> The presence of the (CTA<b>&#x000b7;</b>TAG)<sub>n</sub>(CTG<b>&#x000b7;</b>CAG)<sub>n</sub> ATXN8OS/ATXN8 expansion is not always associated with ataxia. Therefore, some individuals with an <i>ATXN8OS</i>/<i>ATXN8</i> expansion may remain asymptomatic for ataxia throughout their lives.</p><p><b>Maternal vs. paternal <a class="def" href="/books/n/gene/glossary/def-item/penetrance/">penetrance</a> bias.</b> Physicians and genetic counselors should be aware of the differences in male versus female transmission of the (CTA<b>&#x000b7;</b>TAG)<sub>n</sub>(CTG<b>&#x000b7;</b>CAG)<sub>n</sub>
<i>ATXN8OS</i>/<i>ATXN8</i> expansion (see <a href="#sca8.Risk_to_Family_Members">Risk to Family Members</a>, <b>Parents of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a></b> and <b>Offspring of a proband</b>) when providing genetic risk information to family members.</p><p><b>Testing of at-risk asymptomatic adults.</b> Testing of at-risk asymptomatic adults is possible using the techniques described in <a href="#sca8.Molecular_Genetic_Testing">Molecular Genetic Testing</a>. Predictive testing can determine whether an individual has a (CTA<b>&#x000b7;</b>TAG)<sub>n</sub>(CTG<b>&#x000b7;</b>CAG)<sub>n</sub>
<i>ATXN8OS</i>/<i>ATXN8</i> expanded <a class="def" href="/books/n/gene/glossary/def-item/allele/">allele</a> and thus whether that individual is at risk of developing the disease. Because of reduced <a class="def" href="/books/n/gene/glossary/def-item/penetrance/">penetrance</a>, an individual with an <i>ATXN8OS</i>/<i>ATXN8</i> expanded allele is at risk for developing ataxia, but repeat size cannot be used to predict whether ataxia will occur or what the age of onset, severity, or progression of the symptoms will be. An <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> family member should be tested prior to offering testing to at-risk family members to confirm the molecular diagnosis in the family. Predictive testing should be accompanied by <a class="def" href="/books/n/gene/glossary/def-item/genetic-counseling/">genetic counseling</a> to assure that individuals are aware of the limitations of the molecular genetic test and the possible risks associated with predictive testing.</p><p><b>Testing of at-risk individuals younger than age 18 years.</b> Testing of asymptomatic at-risk individuals younger than age 18 years is not recommended for adult-onset conditions for which no effective treatment to prevent the disease or improve the outcome is known. Individuals younger than age 18 years who are symptomatic usually benefit from having a specific diagnosis established. (See also the National Society of Genetic Counselors <a href="http://www.nsgc.org/p/bl/et/blogaid=860" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">position statement</a> on genetic testing of minors for adult-onset conditions and the American Academy of Pediatrics and American College of Medical Genetics and Genomics <a href="http://pediatrics.aappublications.org/content/131/3/620.full.pdf" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">policy statement</a>: ethical and policy issues in genetic testing and screening of children.)</p><p><b>Family planning</b></p><ul><li class="half_rhythm"><div>The optimal time for determination of genetic risk and discussion of the availability of prenatal testing is before pregnancy.</div></li><li class="half_rhythm"><div>It is appropriate to offer <a class="def" href="/books/n/gene/glossary/def-item/genetic-counseling/">genetic counseling</a> (including discussion of potential risks to offspring and reproductive options) to young adults who are <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> or at risk.</div></li></ul><p><b>DNA banking</b> is the storage of DNA (typically extracted from white blood cells) for possible future use. Because it is likely that testing methodology and our understanding of genes, allelic variants, and diseases will improve in the future, consideration should be given to banking DNA of <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals.</p></div><div id="sca8.Prenatal_Testing_and_Preimplantatio"><h3>Prenatal Testing and Preimplantation Genetic Diagnosis</h3><p>Once the <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> has been identified in an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> family member, prenatal testing for a pregnancy at increased risk and <a class="def" href="/books/n/gene/glossary/def-item/preimplantation-genetic-diagnosis/">preimplantation genetic diagnosis</a> for SCA8 are possible.</p><p>Differences in perspective may exist among medical professionals and within families regarding the use of prenatal testing, particularly if the testing is being considered for the purpose of pregnancy termination rather than early diagnosis. While most centers would consider decisions regarding prenatal testing to be the choice of the parents, discussion of these issues is appropriate.</p></div></div><div id="sca8.Resources"><h2 id="_sca8_Resources_">Resources</h2><p>
<i>GeneReviews staff has selected the following disease-specific and/or umbrella
support organizations and/or registries for the benefit of individuals with this disorder
and their families. GeneReviews is not responsible for the information provided by other
organizations. For information on selection criteria, click <a href="/books/n/gene/app4/">here</a>.</i></p><ul><li class="half_rhythm"><div><b>NCBI Genes and Disease</b></div><div><a href="/books/NBK22234/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Spinocerebellar ataxia</a></div></li><li class="half_rhythm"><div><b>Spinocerebellar Ataxia: Making an Informed Choice about Genetic Testing</b></div><div><i>Booklet providing information about Spinocerebellar Ataxia</i></div><div><a href="http://depts.washington.edu/neurolog/images/neurogenetics/ataxia.pdf" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">depts.washington.edu/neurolog/images/neurogenetics/ataxia.pdf</a></div></li><li class="half_rhythm"><div><b>Ataxia UK</b></div><div>Lincoln House</div><div>1-3 Brixton Road</div><div>London SW9 6DE</div><div>United Kingdom</div><div><b>Phone:</b> 0845 644 0606 (helpline); 020 7582 1444 (office); +44 (0) 20 7582 1444 (from abroad)</div><div><b>Email:</b> helpline@ataxia.org.uk; office@ataxia.org.uk</div><div><a href="http://www.ataxia.org.uk" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.ataxia.org.uk</a></div></li><li class="half_rhythm"><div><b>euro-ATAXIA (European Federation of Hereditary Ataxias)</b></div><div>Ataxia UK</div><div>Lincoln House, Kennington Park, 1-3 Brixton Road</div><div>London SW9 6DE</div><div>United Kingdom</div><div><b>Phone:</b> +44 (0) 207 582 1444</div><div><b>Email:</b> smillman@ataxia.org.uk</div><div><a href="https://www.euroataxia.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.euroataxia.org</a></div></li><li class="half_rhythm"><div><b>National Ataxia Foundation</b></div><div>2600 Fernbrook Lane</div><div>Suite 119</div><div>Minneapolis MN 55447</div><div><b>Phone:</b> 763-553-0020</div><div><b>Email:</b> naf@ataxia.org</div><div><a href="http://www.ataxia.org" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.ataxia.org</a></div></li><li class="half_rhythm"><div><b>Spanish Ataxia Federation (FEDAES)</b></div><div>Spain</div><div><b>Phone:</b> 34 983 278 029; 34 985 097 152; 34 634 597 503</div><div><b>Email:</b> sede.valladolid@fedaes.org; sede.gijon@fedaes.org; sede.bilbao@fedaes.org</div><div><a href="http://www.fedaes.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.fedaes.org</a></div></li><li class="half_rhythm"><div><b>CoRDS Registry</b></div><div>Sanford Research</div><div>2301 East 60th Street North</div><div>Sioux Falls SD 57104</div><div><b>Phone:</b> 605-312-6423</div><div><b>Email:</b> sanfordresearch@sanfordhealth.org</div><div><a href="http://www.sanfordresearch.org/SpecialPrograms/cords/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">CoRDS Registry</a></div></li></ul></div><div id="sca8.Molecular_Genetics"><h2 id="_sca8_Molecular_Genetics_">Molecular Genetics</h2><p><i>Information in the Molecular Genetics and OMIM tables may differ from that elsewhere in the GeneReview: tables may contain more recent information. &#x02014;</i>ED.</p><div id="sca8.molgen.TA" class="table"><h3><span class="label">Table A.</span></h3><div class="caption"><p>Spinocerebellar Ataxia Type 8: Genes and Databases</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK1268/table/sca8.molgen.TA/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__sca8.molgen.TA_lrgtbl__"><table class="no_bottom_margin"><tbody><tr><th id="hd_b_sca8.molgen.TA_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;">Gene</th><th id="hd_b_sca8.molgen.TA_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;">Chromosome Locus</th><th id="hd_b_sca8.molgen.TA_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;">Protein</th><th id="hd_b_sca8.molgen.TA_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;">HGMD</th><th id="hd_b_sca8.molgen.TA_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;">ClinVar</th></tr><tr><td headers="hd_b_sca8.molgen.TA_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;"><a href="/gene/724066" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=gene"><i>ATXN8</i></a></td><td headers="hd_b_sca8.molgen.TA_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/genome/gdv/?context=gene&#x00026;acc=724066" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">13q21</a></td><td headers="hd_b_sca8.molgen.TA_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.uniprot.org/uniprot/Q156A1" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Ataxin-8</a></td><td headers="hd_b_sca8.molgen.TA_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.hgmd.cf.ac.uk/ac/gene.php?gene=ATXN8" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">ATXN8</a></td><td headers="hd_b_sca8.molgen.TA_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/clinvar/?term=ATXN8[gene]" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">ATXN8</a></td></tr><tr><td headers="hd_b_sca8.molgen.TA_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;"><a href="/gene/6315" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=gene"><i>ATXN8OS</i></a></td><td headers="hd_b_sca8.molgen.TA_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/genome/gdv/?context=gene&#x00026;acc=6315" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">13q21<wbr style="display:inline-block"></wbr>​.33</a></td><td headers="hd_b_sca8.molgen.TA_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;">Unknown</td><td headers="hd_b_sca8.molgen.TA_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.hgmd.cf.ac.uk/ac/gene.php?gene=ATXN8OS" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">ATXN8OS</a></td><td headers="hd_b_sca8.molgen.TA_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/clinvar/?term=ATXN8OS[gene]" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">ATXN8OS</a></td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt></dt><dd><div id="sca8.TFA.1"><p class="no_margin">Data are compiled from the following standard references: <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> from
<a href="http://www.genenames.org/index.html" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">HGNC</a>;
<a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> <a class="def" href="/books/n/gene/glossary/def-item/locus/">locus</a> from
<a href="http://www.omim.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">OMIM</a>;
protein from <a href="http://www.uniprot.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">UniProt</a>.
For a description of databases (Locus Specific, HGMD, ClinVar) to which links are provided, click
<a href="/books/n/gene/app1/">here</a>.</p></div></dd></dl></div></div></div><div id="sca8.molgen.TB" class="table"><h3><span class="label">Table B.</span></h3><div class="caption"><p>OMIM Entries for Spinocerebellar Ataxia Type 8 (<a href="/omim/603680,608768,613289" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">View All in OMIM</a>) </p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK1268/table/sca8.molgen.TB/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__sca8.molgen.TB_lrgtbl__"><table><tbody><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/603680" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">603680</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">ATAXIN 8 OPPOSITE STRAND; ATXN8OS</td></tr><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/608768" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">608768</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">SPINOCEREBELLAR ATAXIA 8; SCA8</td></tr><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/613289" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">613289</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">ATAXIN 8; ATXN8</td></tr></tbody></table></div></div><p><b>Gene structure.</b> See normal <a class="def" href="/books/n/gene/glossary/def-item/gene-product/">gene product</a>. For a detailed summary of gene and protein information, see <a href="/books/NBK1268/#sca8.molgen.TA">Table A</a>, <b>Gene</b>.</p><p><b>Benign variants.</b> Normal alleles are 15-50 combined (CTA<b>&#x000b7;</b>TAG)<sub>n</sub>(CTG<b>&#x000b7;</b>CAG)<sub>n</sub> repeats in length. Not all expanded alleles (&#x0003e;50 repeats) are pathogenic. The prevalence of <i>ATXN8OS</i>/<i>ATXN8</i> expansions larger than 70 repeats was 0.4% in 2626 control chromosomes [<a class="bk_pop" href="#sca8.REF.ikeda.2004.3">Ikeda et al 2004</a>].</p><p><b>Pathogenic variants.</b> Expanded alleles ranging in size from 71 to more than 800 combined (CTA<b>&#x000b7;</b>TAG)<sub>n</sub>(CTG<b>&#x000b7;</b>CAG)<sub>n</sub> repeats have been found in ataxic individuals. The <i>ATXN8OS</i>/<i>ATXN8</i> expansion shows reduced <a class="def" href="/books/n/gene/glossary/def-item/penetrance/">penetrance</a> and the molecular mechanisms for pathogenesis are not well understood.</p><p>It has been suggested that the CTG<b>&#x000b7;</b>CAG expansion is not involved in the spinocerebellar ataxia type 8 (SCA8) disease process and is simply a non-pathogenic <a class="def" href="/books/n/gene/glossary/def-item/polymorphism/">polymorphism</a> in linkage disequilibrium with another <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> that causes the ataxia [<a class="bk_pop" href="#sca8.REF.stevanin.2000.213">Stevanin et al 2000</a>, <a class="bk_pop" href="#sca8.REF.worth.2000.214">Worth et al 2000</a>]. The linkage data and biologic relationship between repeat length and disease status in the MN-A family have supported the hypothesis that this CTG<b>&#x000b7;</b>CAG expansion is directly associated with ataxia. Haplotype analysis from 37 families with SCA8 showed a common haplotype (and thus common ancestral origin) among most families of northern European origin; two other distinct haplotypes were present in non-northern European families. The identification of independently arising <i>ATXN8OS</i>/<i>ATXN8</i> expansions among families of ataxia with various ethnic backgrounds further supports the direct role of the CTG<b>&#x000b7;</b>CAG expansion in disease pathogenesis [<a class="bk_pop" href="#sca8.REF.ikeda.2004.3">Ikeda et al 2004</a>]. Additionally, the development of a BAC transgenic mouse model of SCA8 demonstrates that the <i>ATXN8OS</i>/<i>ATXN8</i> expansion is pathogenic and can cause a progressive neurologic <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a>, cerebellar deficits, and the accumulation of polyglutamine [<a class="bk_pop" href="#sca8.REF.moseley.2006.758">Moseley et al 2006</a>] and polyalanine [<a class="bk_pop" href="#sca8.REF.zu.2011.260">Zu et al 2011</a>] in Purkinje cells which parallel the human disease. SCA8 BAC transgenic mice also recapitulate the <a class="def" href="/books/n/gene/glossary/def-item/splicing/">splicing</a> abnormalities detected in human SCA8 autopsy tissue [<a class="bk_pop" href="#sca8.REF.daughters.2009.e1000600">Daughters et al 2009</a>].</p><p>While it is now clear that the <i>ATXN8OS</i>/<i>ATXN8</i> expansion can cause ataxia, a number of issues, including reduced <a class="def" href="/books/n/gene/glossary/def-item/penetrance/">penetrance</a>, gender effects, and normal and pathogenic expansion ranges, require further investigation [<a class="bk_pop" href="#sca8.REF.koob.1999.379">Koob et al 1999</a>, <a class="bk_pop" href="#sca8.REF.ikeda.2000a.950">Ikeda et al 2000a</a>, <a class="bk_pop" href="#sca8.REF.moseley.2000a.363">Moseley et al 2000a</a>, <a class="bk_pop" href="#sca8.REF.moseley.2000b.215">Moseley et al 2000b</a>, <a class="bk_pop" href="#sca8.REF.ikeda.2004.3">Ikeda et al 2004</a>].</p><p><b>Normal <a class="def" href="/books/n/gene/glossary/def-item/gene-product/">gene product</a>.</b> The <a class="def" href="/books/n/gene/glossary/def-item/genomic/">genomic</a> organization of the ATXN8OS/ATXN8 <a class="def" href="/books/n/gene/glossary/def-item/locus/">locus</a> differs between humans and mice. In humans, three genes are in close proximity: <i>ATXN8OS</i>, <i>ATXN8</i>, and <i>KLHL1</i>. The expansion is located within both of the overlapping genes (<i>ATXN8OS</i> and <i>ATXN8</i>). In contrast, <i>KLHL1</i> and <i>ATXN8OS</i> overlap at their respective 5' ends, a location approximately 35 kb upstream of the repeat. In mouse, the region containing the repeat is not conserved. While there is a mouse homolog of <i>KLHL1</i> (<i>Klhl1</i>) and there is a much shorter version of the human <i>ATXN8OS</i> (<i>Klhl1as</i>), the mouse <i>Klhl1as</i> is much simpler, with a single <a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> and conservation only to the 5' end of the human <i>ATXN8OS</i> which overlaps <i>KLHL1</i>. Conservation of this short version of <i>ATXN8OS</i> in mouse (<i>Klhl1as</i>) has led to the proposal that <i>ATXN8OS</i> transcripts may regulate <i>KLHL1</i> [<a class="bk_pop" href="#sca8.REF.nemes.2000.1543">Nemes et al 2000</a>, <a class="bk_pop" href="#sca8.REF.benzow.2002.134">Benzow &#x00026; Koob 2002</a>]; to date, no functional studies substantiating this hypothesis have been published. A conditional knockout of murine <i>Klhl1</i> was recently reported to result in a mild atrophy of the molecular layer of the cerebellum, indicating that KLHL1 plays a normal role in cerebellar function. Because it is not known if <i>KLHL1</i> transcripts are downregulated in persons with SCA8 or if the <i>ATXN8OS/ATXN8</i> expansion affects <i>KLHL1</i> regulation, it is not yet clear whether KLHL1 plays a role in SCA8 pathogenesis [<a class="bk_pop" href="#sca8.REF.he.2006.9975">He et al 2006</a>].</p><p><b>Abnormal <a class="def" href="/books/n/gene/glossary/def-item/gene-product/">gene product</a>.</b> Both RNA <a class="def" href="/books/n/gene/glossary/def-item/gain-of-function/">gain-of-function</a> mechanism involving CUG expansion RNAs and polyglutamine expansion proteins are known to contribute to the pathology of other repeat expansion disorders [<a class="bk_pop" href="#sca8.REF.ranum.2006.259">Ranum &#x00026; Cooper 2006</a>].</p><p>Although the pathogenic effects of the <i>ATXN8OS/ATXN8</i> CTG<b>&#x000b7;</b>CAG expansion are not fully understood, studies in last decade indicate that both toxic RNA and toxic protein gain of function mechanisms likely contribute to SCA8 pathogenesis.</p><p>Several lines of evidence suggest that SCA8-related CUG expansion transcripts (<i>ATXN8OS)</i> cause RNA <a class="def" href="/books/n/gene/glossary/def-item/gain-of-function/">gain-of-function</a> effects [<a class="bk_pop" href="#sca8.REF.daughters.2009.e1000600">Daughters et al 2009</a>] similar to those found in <a href="/books/n/gene/myotonic-d/">myotonic dystrophy type 1</a> and <a href="/books/n/gene/myotonic-d2/">myotonic dystrophy type 2</a> [<a class="bk_pop" href="#sca8.REF.ranum.2006.259">Ranum &#x00026; Cooper 2006</a>]:</p><ul><li class="half_rhythm"><div>CUG expansion transcripts form hallmark ribonuclear foci that colocalize with MBNL1/Mbnl1 in <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> human and transgenic mouse brains.</div></li><li class="half_rhythm"><div>Motor deficits are exacerbated in doubly transgenic SCA8 mice that have only one functional copy of the <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> <i>Mbnl1</i> (<i>SCA8</i><sup>+/-</sup>:Mbnl1<sup>&#x00394;E3/+</sup>).</div></li><li class="half_rhythm"><div>SCA8 mouse and human tissue show Mbnl1-regulated <a class="def" href="/books/n/gene/glossary/def-item/splicing/">splicing</a> alterations of CNS targets.</div></li></ul><p>On the other strand, SCA8-related CAG expansion transcripts (<i>ATXN8</i>) express polyGln and polyAla expansion proteins. The polyGln protein accumulates in nuclear aggregates in Purkinje cells [<a class="bk_pop" href="#sca8.REF.moseley.2006.758">Moseley et al 2006</a>]. Additionally, it was recently shown that a polyalanine expansion protein, expressed by repeat-associated non-ATG translation also accumulates in SCA8-<a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> human and mouse brains [<a class="bk_pop" href="#sca8.REF.zu.2011.260">Zu et al 2011</a>]. The relative contribution of toxic RNA and toxic expansion proteins in SCA8 is under further investigation.</p></div><div id="sca8.References"><h2 id="_sca8_References_">References</h2><div id="sca8.Published_Guidelines__Consensus_Sta"><h3>Published Guidelines / Consensus Statements</h3><ul class="simple-list"><li class="half_rhythm"><div class="bk_ref" id="sca8.REF1">American Society of Clinical Oncology. Policy statement update: genetic testing for cancer susceptibility. Available <a href="http://jco.ascopubs.org/content/28/5/893.long" ref="pagearea=cite-ref&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">online</a>. 2010. Accessed 12-6-18.</div></li><li class="half_rhythm"><div class="bk_ref" id="sca8.REF2">National Society of Genetic Counselors. Position statement on genetic testing of minors for adult-onset conditions. Available <a href="http://www.nsgc.org/p/bl/et/blogaid=860" ref="pagearea=cite-ref&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">online</a>. 2018. Accessed 12-6-18.</div></li></ul></div><div id="sca8.Literature_Cited"><h3>Literature Cited</h3><ul class="simple-list"><li class="half_rhythm"><div class="bk_ref" id="sca8.REF.baba.2005.147">Baba Y, Uitti RJ, Farrer MJ, Wszolek ZK. Sporadic SCA8 mutation resembling corticobasal degeneration. <span><span class="ref-journal">Parkinsonism Relat Disord. </span>2005;<span class="ref-vol">11</span>:147–50.</span> [<a href="/pubmed/15823478" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 15823478</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="sca8.REF.barbeau.1984.510">Barbeau A, Roy M, Cunha L, de Vincente AN, Rosenberg RN, Nyhan WL, MacLeod PL, Chazot G, Langston LB, Dawson DM, et al.  The natural history of Machado-Joseph disease. An analysis of 138 personally examined cases. <span><span class="ref-journal">Can J Neurol Sci. </span>1984;<span class="ref-vol">11</span>:510–25.</span> [<a href="/pubmed/6509398" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 6509398</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="sca8.REF.benzow.2002.134">Benzow KA, Koob MD. The KLHL1-antisense transcript (KLHL1AS) is evolutionarily conserved. <span><span class="ref-journal">Mamm Genome. </span>2002;<span class="ref-vol">13</span>:134–41.</span> [<a href="/pubmed/11919683" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 11919683</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="sca8.REF.brusco.2002.923">Brusco A, Cagnoli C, Franco A, Dragone E, Nardacchione A, Grosso E, Mortara P, Mutani R, Migone N, Orsi L. Analysis of SCA8 and SCA12 loci in 134 Italian ataxic patients negative for SCA1-3, 6 and 7 CAG expansions. <span><span class="ref-journal">J Neurol. </span>2002;<span class="ref-vol">249</span>:923–9.</span> [<a href="/pubmed/12140678" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 12140678</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="sca8.REF.brusco.2004.727">Brusco A, Gellera C, Cagnoli C, Saluto A, Castucci A, Michielotto C, Fetoni V, Mariotti C, Migone N, Di Donato S, Taroni F. Molecular genetics of hereditary spinocerebellar ataxia: mutation analysis of spinocerebellar ataxia genes and CAG/CTG repeat expansion detection in 225 Italian families. <span><span class="ref-journal">Arch Neurol. </span>2004;<span class="ref-vol">61</span>:727–33.</span> [<a href="/pubmed/15148151" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 15148151</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="sca8.REF.cellini.2001.1856">Cellini E, Nacmias B, Forleo P, Piacentini S, Guarnieri BM, Serio A, Calabro A, Renzi D, Sorbi S. Genetic and clinical analysis of spinocerebellar ataxia type 8 repeat expansion in Italy. <span><span class="ref-journal">Arch Neurol. </span>2001;<span class="ref-vol">58</span>:1856–9.</span> [<a href="/pubmed/11708995" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 11708995</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="sca8.REF.corral.2005.549">Corral J, Genis D, Banchs I, San Nicolas H, Armstrong J, Volpini V. Giant SCA8 alleles in nine children whose mother has two moderately large ones. <span><span class="ref-journal">Ann Neurol. </span>2005;<span class="ref-vol">57</span>:549–53.</span> [<a href="/pubmed/15786481" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 15786481</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="sca8.REF.daughters.2009.e1000600">Daughters RS, Tuttle DL, Gao W, Ikeda Y, Moseley ML, Ebner TJ, Swanson MS, Ranum LP. RNA gain-of-function in spinocerebellar ataxia type 8. <span><span class="ref-journal">PLoS Genet. </span>2009;<span class="ref-vol">5</span>:e1000600.</span> [<a href="/pmc/articles/PMC2719092/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC2719092</span></a>] [<a href="/pubmed/19680539" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 19680539</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="sca8.REF.gupta.2009.621">Gupta A, Jankovic J. Spinocerebellar ataxia 8: variable phenotype and unique pathogenesis. <span><span class="ref-journal">Parkinsonism Relat Disord. </span>2009;<span class="ref-vol">15</span>:621–6.</span> [<a href="/pubmed/19559641" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 19559641</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="sca8.REF.day.2000.649">Day JW, Schut LJ, Moseley ML, Durand AC, Ranum LP. Spinocerebellar ataxia type 8: clinical features in a large family. <span><span class="ref-journal">Neurology. </span>2000;<span class="ref-vol">55</span>:649–57.</span> [<a href="/pubmed/10980728" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 10980728</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="sca8.REF.factor.2005.462">Factor SA, Qian J, Lava NS, Hubbard JD, Payami H. False-positive SCA8 gene test in a patient with pathologically proven multiple system atrophy. <span><span class="ref-journal">Ann Neurol. </span>2005;<span class="ref-vol">57</span>:462–3.</span> [<a href="/pubmed/15732096" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 15732096</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="sca8.REF.felling.2005.136">Felling RJ, Barron TF. Early onset of ataxia in a child with a pathogenic SCA8 allele. <span><span class="ref-journal">Pediatr Neurol. </span>2005;<span class="ref-vol">33</span>:136–8.</span> [<a href="/pubmed/16087061" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 16087061</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="sca8.REF.flanigan.1996.392">Flanigan K, Gardner K, Alderson K, Galster B, Otterud B, Leppert MF, Kaplan C, Ptacek LJ. Autosomal dominant spinocerebellar ataxia with sensory axonal neuropathy (SCA4): clinical description and genetic localization to chromosome 16q22.1. <span><span class="ref-journal">Am J Hum Genet. </span>1996;<span class="ref-vol">59</span>:392–9.</span> [<a href="/pmc/articles/PMC1914712/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC1914712</span></a>] [<a href="/pubmed/8755926" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 8755926</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="sca8.REF.gouw.1995.89">Gouw LG, Kaplan CD, Haines JH, Digre KB, Rutledge SL, Matilla A, Leppert M, Zoghbi HY, Ptacek LJ. Retinal degeneration characterizes a spinocerebellar ataxia mapping to chromosome 3p. <span><span class="ref-journal">Nat Genet. </span>1995;<span class="ref-vol">10</span>:89–93.</span> [<a href="/pubmed/7647799" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 7647799</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="sca8.REF.he.2006.9975">He Y, Zu T, Benzow KA, Orr HT, Clark HB, Koob MD. Targeted deletion of a single Sca8 ataxia locus allele in mice causes abnormal gait, progressive loss of motor coordination, and Purkinje cell dendritic deficits. <span><span class="ref-journal">J Neurosci. </span>2006;<span class="ref-vol">26</span>:9975–82.</span> [<a href="/pmc/articles/PMC6674467/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC6674467</span></a>] [<a href="/pubmed/17005861" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 17005861</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="sca8.REF.ikeda.2004.3">Ikeda Y, Dalton JC, Moseley ML, Gardner KL, Bird TD, Ashizawa T, Seltzer WK, Pandolfo M, Milunsky A, Potter NT, Shoji M, Vincent JB, Day JW, Ranum LP. Spinocerebellar ataxia type 8: molecular genetic comparisons and haplotype analysis of 37 families with ataxia. <span><span class="ref-journal">Am J Hum Genet. </span>2004;<span class="ref-vol">75</span>:3–16.</span> [<a href="/pmc/articles/PMC1182005/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC1182005</span></a>] [<a href="/pubmed/15152344" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 15152344</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="sca8.REF.ikeda.2000a.950">Ikeda Y, Shizuka M, Watanabe M, Okamoto K, Shoji M. Molecular and clinical analyses of spinocerebellar ataxia type 8 in Japan. <span><span class="ref-journal">Neurology. </span>2000a;<span class="ref-vol">54</span>:950–5.</span> [<a href="/pubmed/10690991" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 10690991</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="sca8.REF.ikeda.2000b.76">Ikeda Y, Shizuka-Ikeda M, Watanabe M, Schmitt M, Okamoto K, Shoji M. Asymptomatic CTG expansion at the SCA8 locus is associated with cerebellar atrophy on MRI. <span><span class="ref-journal">J Neurol Sci. </span>2000b;<span class="ref-vol">182</span>:76–9.</span> [<a href="/pubmed/11102643" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 11102643</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="sca8.REF.izumi.2003.704">Izumi Y, Maruyama H, Oda M, Morino H, Okada T, Ito H, Sasaki I, Tanaka H, Komure O, Udaka F, Nakamura S, Kawakami H. SCA8 repeat expansion: large CTA/CTG repeat alleles are more common in ataxic patients, including those with SCA6. <span><span class="ref-journal">Am J Hum Genet. </span>2003;<span class="ref-vol">72</span>:704–9.</span> [<a href="/pmc/articles/PMC1180244/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC1180244</span></a>] [<a href="/pubmed/12545428" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 12545428</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="sca8.REF.juvonen.2005.154">Juvonen V, Hietala M, Kairisto V, Savontaus ML. The occurrence of dominant spinocerebellar ataxias among 251 Finnish ataxia patients and the role of predisposing large normal alleles in a genetically isolated population. <span><span class="ref-journal">Acta Neurol Scand. </span>2005;<span class="ref-vol">111</span>:154–62.</span> [<a href="/pubmed/15691283" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 15691283</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="sca8.REF.juvonen.2000.354">Juvonen V, Hietala M, Paivarinta M, Rantamaki M, Hakamies L, Kaakkola S, Vierimaa O, Penttinen M, Savontaus ML. Clinical and genetic findings in Finnish ataxia patients with the spinocerebellar ataxia 8 repeat expansion. <span><span class="ref-journal">Ann Neurol. </span>2000;<span class="ref-vol">48</span>:354–61.</span> [<a href="/pubmed/10976642" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 10976642</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="sca8.REF.kim.2013.274">Kim JS, Son TO, Youn J, Ki CS, Cho JW. Non-Ataxic Phenotypes of SCA8 Mimicking Amyotrophic Lateral Sclerosis and Parkinson Disease. <span><span class="ref-journal">J Clin Neurol. </span>2013;<span class="ref-vol">9</span>:274–9.</span> [<a href="/pmc/articles/PMC3840139/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3840139</span></a>] [<a href="/pubmed/24285970" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 24285970</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="sca8.REF.koob.1999.379">Koob MD, Moseley ML, Schut LJ, Benzow KA, Bird TD, Day JW, Ranum LP. An untranslated CTG expansion causes a novel form of spinocerebellar ataxia (SCA8). <span><span class="ref-journal">Nat Genet. </span>1999;<span class="ref-vol">21</span>:379–84.</span> [<a href="/pubmed/10192387" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 10192387</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="sca8.REF.lilja.2005.31">Lilja A, Hamalainen P, Kaitaranta E, Rinne R. Cognitive impairment in spinocerebellar ataxia type 8. <span><span class="ref-journal">J Neurol Sci. </span>2005;<span class="ref-vol">237</span>:31–8.</span> [<a href="/pubmed/15958266" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 15958266</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="sca8.REF.maschke.2005.1405">Maschke M, Oehlert G, Xie TD, Perlman S, Subramony SH, Kumar N, Ptacek LJ, Gomez CM. Clinical feature profile of spinocerebellar ataxia type 1-8 predicts genetically defined subtypes. <span><span class="ref-journal">Mov Disord. </span>2005;<span class="ref-vol">20</span>:1405–12.</span> [<a href="/pubmed/16037936" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 16037936</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="sca8.REF.matsuura.2000.191">Matsuura T, Yamagata T, Burgess DL, Rasmussen A, Grewal RP, Watase K, Khajavi M, McCall AE, Davis CF, Zu L, Achari M, Pulst SM, Alonso E, Noebels JL, Nelson DL, Zoghbi HY, Ashizawa T. Large expansion of the ATTCT pentanucleotide repeat in spinocerebellar ataxia type 10. <span><span class="ref-journal">Nat Genet. </span>2000;<span class="ref-vol">26</span>:191–4.</span> [<a href="/pubmed/11017075" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 11017075</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="sca8.REF.moseley.2000a.363">Moseley ML, Jacobsen J, Liquori C, Davis L, Ikeda Y, Bird TD, Spiegel R, Ashizawa T, Pandolfo M, Potter N, Schaefer F, Milunsky A, Kennedy J, Seltzer W, Atwood L, Vincent J, Day JW, Ranum LPW. SCA8 CTG expansion: evidence for a common haplotype and highly mutable region on both ataxia and non-ataxia chromosomes. <span><span class="ref-journal">Am J Hum Genet. </span>2000a;<span class="ref-vol">67</span>:363.</span></div></li><li class="half_rhythm"><div class="bk_ref" id="sca8.REF.moseley.2000b.215">Moseley ML, Schut LJ, Bird TD, Day JW, Ranum LP. Reply-. <span><span class="ref-journal">Nat Genet. </span>2000b;<span class="ref-vol">24</span>:215.</span> [<a href="/pubmed/10700169" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 10700169</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="sca8.REF.moseley.2000c.2125">Moseley ML, Schut LJ, Bird TD, Koob MD, Day JW, Ranum LP. SCA8 CTG repeat: en masse contractions in sperm and intergenerational sequence changes may play a role in reduced penetrance. <span><span class="ref-journal">Hum Mol Genet. </span>2000c;<span class="ref-vol">9</span>:2125–30.</span> [<a href="/pubmed/10958651" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 10958651</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="sca8.REF.moseley.2006.758">Moseley ML, Zu T, Ikeda Y, Gao W, Mosemiller AK, Daughters RS, Chen G, Weatherspoon MR, Clark HB, Ebner TJ, Day JW, Ranum LP. Bidirectional expression of CUG and CAG expansion transcripts and intranuclear polyglutamine inclusions in spinocerebellar ataxia type 8. <span><span class="ref-journal">Nat Genet. </span>2006;<span class="ref-vol">38</span>:758–69.</span> [<a href="/pubmed/16804541" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 16804541</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="sca8.REF.mosemiller.2003.175">Mosemiller AK, Dalton JC, Day JW, Ranum LP. Molecular genetics of spinocerebellar ataxia type 8 (SCA8). <span><span class="ref-journal">Cytogenet Genome Res. </span>2003;<span class="ref-vol">100</span>:175–83.</span> [<a href="/pubmed/14526178" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 14526178</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="sca8.REF.munhoz.2006.191">Munhoz RP, Teive HA, Raskin S, Troiano AR. Atypical parkinsonism and SCA8. <span><span class="ref-journal">Parkinsonism Relat Disord. </span>2006;<span class="ref-vol">12</span>:191–2.</span> [<a href="/pubmed/16368257" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 16368257</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="sca8.REF.nemes.2000.1543">Nemes JP, Benzow KA, Moseley ML, Ranum LP, Koob MD. The SCA8 transcript is an antisense RNA to a brain-specific transcript encoding a novel actin-binding protein (KLHL1). <span><span class="ref-journal">Hum Mol Genet. </span>2000;<span class="ref-vol">9</span>:1543–51.</span> [<a href="/pubmed/10888605" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 10888605</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="sca8.REF.orozco_diaz.1990.1369">Orozco Diaz G, Nodarse Fleites A, Cordov&#x000e9;s Sagaz R, Auburger G. Autosomal dominant cerebellar ataxia: clinical analysis of 263 patients from a homogeneous population in Holgu&#x000ed;n, Cuba. <span><span class="ref-journal">Neurology. </span>1990;<span class="ref-vol">40</span>:1369–75.</span> [<a href="/pubmed/2392220" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 2392220</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="sca8.REF.pato.2000.854">Pato CN, Macedo A, Ambrosio A, Vincent JB, Bauer A, Schindler K, Xu J, Coelho I, Dourado A, Valente J, Azevedo MH, Kennedy JL, Pato MT. Detection of expansion regions in Portuguese bipolar families. <span><span class="ref-journal">Am J Med Genet. </span>2000;<span class="ref-vol">96</span>:854–7.</span> [<a href="/pubmed/11121196" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 11121196</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="sca8.REF.ranum.2006.259">Ranum LP, Cooper TA. RNA-mediated neuromuscular disorders. <span><span class="ref-journal">Annu Rev Neurosci. </span>2006;<span class="ref-vol">29</span>:259–77.</span> [<a href="/pubmed/16776586" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 16776586</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="sca8.REF.ranum.1999.466">Ranum LPW, Moseley ML, Leppet MF, et al.  Massive CTG expansions and deletions may reduce penetrance of spinocerebellar ataxia type 8. <span><span class="ref-journal">Am J Hum Genet. </span>1999;<span class="ref-vol">65</span>:466.</span></div></li><li class="half_rhythm"><div class="bk_ref" id="sca8.REF.ranum.1994.280">Ranum LP, Schut LJ, Lundgren JK, Orr HT, Livingston DM. Spinocerebellar ataxia type 5 in a family descended from the grandparents of President Lincoln maps to chromosome 11. <span><span class="ref-journal">Nat Genet. </span>1994;<span class="ref-vol">8</span>:280–4.</span> [<a href="/pubmed/7874171" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 7874171</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="sca8.REF.rasmussen.2001.234">Rasmussen A, Matsuura T, Ruano L, Yescas P, Ochoa A, Ashizawa T, Alonso E. Clinical and genetic analysis of four Mexican families with spinocerebellar ataxia type 10. <span><span class="ref-journal">Ann Neurol. </span>2001;<span class="ref-vol">50</span>:234–9.</span> [<a href="/pubmed/11506407" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 11506407</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="sca8.REF.sch_ls.2003.110">Sch&#x000f6;ls L, Bauer I, Z&#x000fc;hlke C, Schulte T, K&#x000f6;lmel C, B&#x000fc;rk K, Topka H, Bauer P, Przuntek H, Riess O. Do CTG expansions at the SCA8 locus cause ataxia? <span><span class="ref-journal">Ann Neurol. </span>2003;<span class="ref-vol">54</span>:110–5.</span> [<a href="/pubmed/12838526" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 12838526</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="sca8.REF.schut.1950.535">Schut JW. Hereditary ataxia: clinical study through six generations. <span><span class="ref-journal">Arch Neurol Psychiatr. </span>1950;<span class="ref-vol">63</span>:535–68.</span></div></li><li class="half_rhythm"><div class="bk_ref" id="sca8.REF.silveira.2000.830">Silveira I, Alonso I, Guimaraes L, Mendonca P, Santos C, Maciel P, Fidalgo De Matos JM, Costa M, Barbot C, Tuna A, Barros J, Jardim L, Coutinho P, Sequeiros J. High germinal instability of the (CTG)n at the SCA8 locus of both expanded and normal alleles. <span><span class="ref-journal">Am J Hum Genet. </span>2000;<span class="ref-vol">66</span>:830–40.</span> [<a href="/pmc/articles/PMC1288166/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC1288166</span></a>] [<a href="/pubmed/10712199" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 10712199</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="sca8.REF.sobrido.2001.1310">Sobrido MJ, Cholfin JA, Perlman S, Pulst SM, Geschwind DH. SCA8 repeat expansions in ataxia: a controversial association. <span><span class="ref-journal">Neurology. </span>2001;<span class="ref-vol">57</span>:1310–2.</span> [<a href="/pubmed/11591855" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 11591855</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="sca8.REF.stevanin.2000.213">Stevanin G, Herman A, Drr A, Jodice C, Frontali M, Agid Y, Brice A. Are (CTG)n expansions at the SCA8 locus rare polymorphisms? <span><span class="ref-journal">Nat Genet. </span>2000;<span class="ref-vol">24</span>:213.</span> [<a href="/pubmed/10700167" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 10700167</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="sca8.REF.stone.2001.229">Stone J, Smith L, Watt K, Barron L, Zeman A. Incoordinated thought and emotion in spinocerebellar ataxia type 8. <span><span class="ref-journal">J Neurol. </span>2001;<span class="ref-vol">248</span>:229–32.</span> [<a href="/pubmed/11355159" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 11355159</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="sca8.REF.su_ek.2004.101">Su&#x00142;ek A, Hoffman-Zacharska D, Bednarska-Makaruk M, Szirkowiec W, Zaremba J. Polymorphism of trinucleotide repeats in non-translated regions of SCA8 and SCA12 genes: allele distribution in a Polish control group. <span><span class="ref-journal">J Appl Genet. </span>2004;<span class="ref-vol">45</span>:101–5.</span> [<a href="/pubmed/14960773" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 14960773</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="sca8.REF.taz_n.2002.404">Taz&#x000f3;n B, Badenas C, Jim&#x000e9;nez L, Mu&#x000f1;oz E, Mil&#x000e0; M. SCA8 in the Spanish population including one homozygous patient. <span><span class="ref-journal">Clin Genet. </span>2002;<span class="ref-vol">62</span>:404–9.</span> [<a href="/pubmed/12431257" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 12431257</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="sca8.REF.topisirovic.2002.321">Topisirovic I, Dragasevic N, Savic D, Ristic A, Keckarevic M, Keckarevic D, Culjkovic B, Petrovic I, Romac S, Kostic VS. Genetic and clinical analysis of spinocerebellar ataxia type 8 repeat expansion in Yugoslavia. <span><span class="ref-journal">Clin Genet. </span>2002;<span class="ref-vol">62</span>:321–4.</span> [<a href="/pubmed/12372061" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 12372061</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="sca8.REF.ushe.2012.1741">Ushe M, Perlmutter JS. Oromandibular and lingual dystonia associated with spinocerebellar ataxia type 8. <span><span class="ref-journal">Mov Disord. </span>2012;<span class="ref-vol">27</span>:1741–2.</span> [<a href="/pmc/articles/PMC3539208/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3539208</span></a>] [<a href="/pubmed/23283653" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 23283653</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="sca8.REF.vincent.2000a.819">Vincent JB, Neves-Pereira ML, Paterson AD, Yamamoto E, Parikh SV, Macciardi F, Gurling HM, Potkin SG, Pato CN, Macedo A, Kovacs M, Davies M, Lieberman JA, Meltzer HY, Petronis A, Kennedy JL. An unstable trinucleotide-repeat region on chromosome 13 implicated in spinocerebellar ataxia: a common expansion locus. <span><span class="ref-journal">Am J Hum Genet. </span>2000a;<span class="ref-vol">66</span>:819–29.</span> [<a href="/pmc/articles/PMC1288165/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC1288165</span></a>] [<a href="/pubmed/10712198" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 10712198</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="sca8.REF.vincent.2000b.873">Vincent JB, Yuan QP, Schalling M, Adolfsson R, Azevedo MH, Macedo A, Bauer A, Dalla Torre C, Medeiros HM, Pato MT, Pato CN, Bowen T, Guy CA, Owen MJ, O'Donovan MC, Paterson AD, Petronis A, Kennedy JL. Long repeat tracts at SCA8 in major psychosis. <span><span class="ref-journal">Am J Med Genet. </span>2000b;<span class="ref-vol">96</span>:873–6.</span> [<a href="/pubmed/11121201" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 11121201</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="sca8.REF.worth.2000.214">Worth PF, Houlden H, Giunti P, Davis MB, Wood NW. Large, expanded repeats in SCA8 are not confined to patients with cerebellar ataxia. <span><span class="ref-journal">Nat Genet. </span>2000;<span class="ref-vol">24</span>:214–5.</span> [<a href="/pubmed/10700168" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 10700168</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="sca8.REF.zeman.2004.459">Zeman A, Stone J, Porteous M, Burns E, Barron L, Warner J. Spinocerebellar ataxia type 8 in Scotland: genetic and clinical features in seven unrelated cases and a review of published reports. <span><span class="ref-journal">J Neurol Neurosurg Psychiatry. </span>2004;<span class="ref-vol">75</span>:459–65.</span> [<a href="/pmc/articles/PMC1738991/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC1738991</span></a>] [<a href="/pubmed/14966165" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 14966165</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="sca8.REF.zu.2011.260">Zu T, Gibbens B, Doty NS, Gomes-Pereira M, Huguet A, Stone MD, Margolis J, Peterson M, Markowski TW, Ingram MA, Nan Z, Forster C, Low WC, Schoser B, Somia NV, Clark HB, Schmechel S, Bitterman PB, Gourdon G, Swanson MS, Moseley M, Ranum LP. Non-ATG-initiated translation directed by microsatellite expansions. <span><span class="ref-journal">Proc Natl Acad Sci U S A. </span>2011;<span class="ref-vol">108</span>:260–5.</span> [<a href="/pmc/articles/PMC3017129/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3017129</span></a>] [<a href="/pubmed/21173221" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 21173221</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="sca8.REF.zhuchenko.1997.62">Zhuchenko O, Bailey J, Bonnen P, Ashizawa T, Stockton DW, Amos C, Dobyns WB, Subramony SH, Zoghbi HY, Lee CC. Autosomal dominant cerebellar ataxia (SCA6) associated with small polyglutamine expansions in the alpha 1A-voltage-dependent calcium channel. <span><span class="ref-journal">Nat Genet. </span>1997;<span class="ref-vol">15</span>:62–9.</span> [<a href="/pubmed/8988170" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 8988170</span></a>]</div></li></ul></div></div><div id="sca8.Chapter_Notes"><h2 id="_sca8_Chapter_Notes_">Chapter Notes</h2><div id="sca8.Revision_History"><h3>Revision History</h3><ul><li class="half_rhythm"><div>3 April 2014 (me) Comprehensive update posted live</div></li><li class="half_rhythm"><div>7 February 2007 (me) Comprehensive update posted live</div></li><li class="half_rhythm"><div>15 March 2004 (me) Comprehensive update posted live</div></li><li class="half_rhythm"><div>27 November 2001 (me) Review posted live</div></li><li class="half_rhythm"><div>15 February 2001 (jd) Original submission</div></li></ul></div></div><div id="bk_toc_contnr"></div></div></div>
            <div class="post-content"><div><div class="half_rhythm"><a href="/books/about/copyright/">Copyright</a> © 1993-2019, University of Washington, Seattle. GeneReviews is
a registered trademark of the University of Washington, Seattle. All rights
reserved.<p class="small">GeneReviews® chapters are owned by the University of Washington. Permission is
hereby granted to reproduce, distribute, and translate copies of content materials for
noncommercial research purposes only, provided that (i) credit for source (<a href="http://www.genereviews.org/" ref="pagearea=meta&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">http://www.genereviews.org/</a>) and copyright (© 1993-2019 University of
Washington) are included with each copy; (ii) a link to the original material is provided
whenever the material is published elsewhere on the Web; and (iii) reproducers,
distributors, and/or translators comply with the <a href="/books/n/gene/GRcopyright_permiss/">GeneReviews® Copyright Notice and Usage
Disclaimer</a>. No further modifications are allowed. For clarity, excerpts
of GeneReviews chapters for use in lab reports and clinic notes are a permitted
use.</p><p class="small">For more information, see the <a href="/books/n/gene/GRcopyright_permiss/">GeneReviews® Copyright Notice and Usage
Disclaimer</a>.</p><p class="small">For questions regarding permissions or whether a specified use is allowed,
contact: <a href="mailto:dev@null" data-email="ude.wu@tssamda" class="oemail">ude.wu@tssamda</a>.</p></div><div class="small"><span class="label">Bookshelf ID: NBK1268</span><span class="label">PMID: <a href="/pubmed/20301445" title="PubMed record of this page" ref="pagearea=meta&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">20301445</a></span></div><div style="margin-top:2em" class="bk_noprnt"><a class="bk_cntns" href="/books/n/gene/">GeneReviews by Title</a><div class="pagination bk_noprnt"><a class="active page_link prev" href="/books/n/gene/sca7/" title="Previous page in this title">&lt; Prev</a><a class="active page_link next" href="/books/n/gene/sca10/" title="Next page in this title">Next &gt;</a></div></div></div></div>
            
        </div>

        <!-- Custom content below content -->
        <div class="col4">
            
        </div>
        
        
        <!-- Book content -->
        
        <!-- Custom contetnt below bottom nav -->
        <div class="col5">
            
        </div>
    </div>

    <div id="rightcolumn" class="four_col col last">
        <!-- Custom content above discovery portlets -->
        <div class="col6">
            <div id="ncbi_share_book"><a href="#" class="ncbi_share" data-ncbi_share_config="popup:false,shorten:true" ref="id=NBK1268&amp;db=books">Share</a></div>

        </div>
        <div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Views</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="PDF_download" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="/books/NBK1268/?report=reader">PubReader</a></li><li><a href="/books/NBK1268/?report=printable">Print View</a></li><li><a data-jig="ncbidialog" href="#_ncbi_dlg_citbx_NBK1268" data-jigconfig="width:400,modal:true">Cite this Page</a><div id="_ncbi_dlg_citbx_NBK1268" style="display:none" title="Cite this Page"><div class="bk_tt">Ayhan F, Ikeda Y, Dalton JC, et al. Spinocerebellar Ataxia Type 8. 2001 Nov 27 [Updated 2014 Apr 3]. In: Adam MP, Ardinger HH, Pagon RA, et al., editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2019. <span class="bk_cite_avail"></span></div></div></li><li><a href="/books/NBK1268/pdf/Bookshelf_NBK1268.pdf">PDF version of this page</a> (469K)</li><li><a href="#" class="toggle-glossary-link" title="Enable/disable links to the glossary">Disable Glossary Links</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>In this GeneReview</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="page-toc" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="#sca8.Summary" ref="log$=inpage&amp;link_id=inpage">Summary</a></li><li><a href="#sca8.Diagnosis" ref="log$=inpage&amp;link_id=inpage">Diagnosis</a></li><li><a href="#sca8.Clinical_Characteristics" ref="log$=inpage&amp;link_id=inpage">Clinical Characteristics</a></li><li><a href="#sca8.Genetically_Related_Allelic_Disorde" ref="log$=inpage&amp;link_id=inpage">Genetically Related (Allelic) Disorders</a></li><li><a href="#sca8.Differential_Diagnosis" ref="log$=inpage&amp;link_id=inpage">Differential Diagnosis</a></li><li><a href="#sca8.Management" ref="log$=inpage&amp;link_id=inpage">Management</a></li><li><a href="#sca8.Genetic_Counseling" ref="log$=inpage&amp;link_id=inpage">Genetic Counseling</a></li><li><a href="#sca8.Resources" ref="log$=inpage&amp;link_id=inpage">Resources</a></li><li><a href="#sca8.Molecular_Genetics" ref="log$=inpage&amp;link_id=inpage">Molecular Genetics</a></li><li><a href="#sca8.References" ref="log$=inpage&amp;link_id=inpage">References</a></li><li><a href="#sca8.Chapter_Notes" ref="log$=inpage&amp;link_id=inpage">Chapter Notes</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>GeneReviews Links</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="source-links" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="/books/n/gene/advanced/"><i>GeneReviews</i> Advanced Search</a></li><li><a href="/books/n/gene/glossary/"><i>GeneReviews</i> Glossary</a></li><li><a href="/books/n/gene/resource_mats/">Resource Materials</a> <span class="bk_hlight1">NEW FEATURE</span></li><li><a href="/books/n/gene/updates/">New in <i>GeneReviews</i></a></li><li><a href="/books/n/gene/authors/">Author List</a></li><li><a href="/books/n/gene/prospective_authors/">For Current/Prospective Authors</a></li><li><a href="/books/n/gene/GRpersonnel/"><i>GeneReviews</i> Personnel</a></li><li><a href="/books/n/gene/howto_linkin/">Download/Link to <i>GeneReviews</i></a></li><li><a href="/books/n/gene/contact_us/">Contact Us</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Tests in GTR by Gene</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="document-links" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="https://www.ncbi.nlm.nih.gov/gtr/tests/?term=724066[geneid]" ref="pagearea=document-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri&amp;link_id=tests_in_gtr_by_gene">ATXN8</a></li><li><a href="https://www.ncbi.nlm.nih.gov/gtr/tests/?term=6315[geneid]" ref="pagearea=document-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri&amp;link_id=tests_in_gtr_by_gene">ATXN8OS</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Related information</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="discovery_db_links" id="Shutter"></a></div><div class="portlet_content"><ul><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=omim&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_omim&amp;IdsFromResult=1482044" ref="log$=recordlinks">OMIM</a><div class="brieflinkpop offscreen_noflow">Related OMIM records</div></li><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=pmc&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_pmc_refs&amp;IdsFromResult=1482044" ref="log$=recordlinks">PMC</a><div class="brieflinkpop offscreen_noflow">PubMed Central citations</div></li><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=pubmed&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_pubmed_refs&amp;IdsFromResult=1482044" ref="log$=recordlinks">PubMed</a><div class="brieflinkpop offscreen_noflow">Links to PubMed</div></li><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=gene&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_gene&amp;IdsFromResult=1482044" ref="log$=recordlinks">Gene</a><div class="brieflinkpop offscreen_noflow">Locus Links</div></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Similar articles in PubMed</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="PBooksDiscovery_RA" id="Shutter"></a></div><div class="portlet_content"><ul><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/20301363" ref="ordinalpos=1&amp;linkpos=1&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Spinocerebellar Ataxia Type 1</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Spinocerebellar Ataxia Type 1<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Opal P, Ashizawa T. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/20301573" ref="ordinalpos=1&amp;linkpos=2&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Spinocerebellar Ataxia Type 14</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Spinocerebellar Ataxia Type 14<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Chen DH, Bird TD, Raskind WH. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/20301452" ref="ordinalpos=1&amp;linkpos=3&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Spinocerebellar Ataxia Type 2</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Spinocerebellar Ataxia Type 2<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Pulst SM. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/10958651" ref="ordinalpos=1&amp;linkpos=4&amp;log$=relatedarticles&amp;logdbfrom=pubmed">SCA8 CTG repeat: en masse contractions in sperm and intergenerational sequence changes may play a role in reduced penetrance.</a><span class="source">[Hum Mol Genet. 2000]</span><div class="brieflinkpop offscreen_noflow">SCA8 CTG repeat: en masse contractions in sperm and intergenerational sequence changes may play a role in reduced penetrance.<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Moseley ML, Schut LJ, Bird TD, Koob MD, Day JW, Ranum LP. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">Hum Mol Genet. 2000 Sep 1; 9(14):2125-30. </em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/20301319" ref="ordinalpos=1&amp;linkpos=5&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Spinocerebellar Ataxia Type 6</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Spinocerebellar Ataxia Type 6<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Casey HL, Gomez CM. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li></ul><a class="seemore" href="/sites/entrez?db=pubmed&amp;cmd=link&amp;linkname=pubmed_pubmed_reviews&amp;uid=20301445" ref="ordinalpos=1&amp;log$=relatedreviews_seeall&amp;logdbfrom=pubmed">See reviews...</a><a class="seemore" href="/sites/entrez?db=pubmed&amp;cmd=link&amp;linkname=pubmed_pubmed&amp;uid=20301445" ref="ordinalpos=1&amp;log$=relatedarticles_seeall&amp;logdbfrom=pubmed">See all...</a></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Recent Activity</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="recent_activity" id="Shutter"></a></div><div class="portlet_content"><div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" id="HTDisplay" class=""><div class="action"><a href="javascript:historyDisplayState('ClearHT')">Clear</a><a href="javascript:historyDisplayState('HTOff')" class="HTOn">Turn Off</a><a href="javascript:historyDisplayState('HTOn')" class="HTOff">Turn On</a></div><ul id="activity"><li class="ra_rcd ralinkpopper two_line"><a class="htb ralinkpopperctrl" ref="log$=activity&amp;linkpos=1" href="/portal/utils/pageresolver.fcgi?recordid=5e040d5975f66d18aa96b486">Spinocerebellar Ataxia Type 8 - GeneReviews®</a><div class="ralinkpop offscreen_noflow">Spinocerebellar Ataxia Type 8 - GeneReviews®<div class="brieflinkpopdesc"></div></div><div class="tertiary"></div></li></ul><p class="HTOn">Your browsing activity is empty.</p><p class="HTOff">Activity recording is turned off.</p><p id="turnOn" class="HTOff"><a href="javascript:historyDisplayState('HTOn')">Turn recording back on</a></p><a class="seemore" href="/sites/myncbi/recentactivity">See more...</a></div></div></div>
        
        <!-- Custom content below discovery portlets -->
        <div class="col7">
            
        </div>
    </div>
</div>

<!-- Custom content after all -->
<div class="col8">
    
</div>
<div class="col9">
    
</div>

<script type="text/javascript" src="/corehtml/pmc/js/jquery.scrollTo-1.4.2.js"></script>
<script type="text/javascript">
    (function($){
        $('.skiplink').each(function(i, item){
            var href = $($(item).attr('href'));
            href.attr('tabindex', '-1').addClass('skiptarget'); // ensure the target can receive focus
            $(item).on('click', function(event){
                event.preventDefault();
                $.scrollTo(href, 0, {
                    onAfter: function(){
                        href.focus();
                    }
                });
            });
        });
    })(jQuery);
</script>
                        </div>
                        <div class="bottom">
                            
                            <div id="NCBIFooter_dynamic">
    <a id="help-desk-link" class="help_desk" href="" target="_blank">Support Center</a>
    <a id="help-desk-link" class="help_desk" href="https://support.ncbi.nlm.nih.gov/ics/support/KBList.asp?Time=2019-12-25T20:31:05-05:00&amp;Snapshot=%2Fprojects%2Fbooks%2FPBooks@5.22&amp;Host=portal105&amp;ncbi_phid=CE8C6712E03F696100000000086F02D2&amp;ncbi_session=CE8C6712E040D581_2159SID&amp;from=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fbooks%2FNBK1268%2F&amp;Db=pmc&amp;folderID=134&amp;Ncbi_App=bookshelf&amp;Page=literature&amp;style=classic&amp;deptID=28049" target="_blank">Support Center</a>
    
</div>

                            <div class="footer" id="footer">
    
    <div class="subfooter"> </div><script type="text/javascript" src="/portal/portal3rc.fcgi/static/js/preloaderWidget.js"> </script>
    <div id="external-disclaimer" class="offscreen_noflow">
        External link. Please review our <a href="https://www.nlm.nih.gov/privacy.html">privacy policy</a>.
    </div>    
    <div id="ncbifooter" class="contact_info">      
        <div id="footer-contents-right">
            <div id="nlm_thumb_logo">
                <a href="https://www.nlm.nih.gov" title="NLM">NLM</a>
            </div>
            <div id="nih_thumb_logo">
                <a href="https://www.nih.gov" title="NIH">NIH</a>
            </div>
            <div id="hhs_thumb_logo">
                <a href="https://www.hhs.gov" title="DHHS">DHHS</a>
            </div>
            <div id="usagov_thumb_logo">
                <a href="https://www.usa.gov" title="USA.gov">USA.gov</a>
            </div>         
        </div>
        
        <div id="footer-contents-left">
            <p class="address vcard">
                <span class="url">
                    <a class="fn url newdomain" href="https://www.ncbi.nlm.nih.gov">National Center for
                        Biotechnology Information</a>,
                </span> <span class="org url newdomain"><a href="https://www.nlm.nih.gov/">U.S. National Library of Medicine</a></span>
                <span class="adr">
                    <span class="street-address">8600 Rockville Pike</span>, <span class="locality">Bethesda</span>
                    <span class="region">MD</span>, <span class="postal-code">20894</span>
                    <span class="country-name">USA</span>
                </span>
            </p>
            
            <a href="/home/about/policies.shtml">Policies and Guidelines</a> | <a href="/home/about/contact.shtml">Contact</a>
        </div>
    </div>
    <script type="text/javascript" src="/portal/portal3rc.fcgi/rlib/js/InstrumentOmnitureBaseJS/InstrumentNCBIConfigJS/InstrumentNCBIBaseJS/InstrumentPageStarterJS.js?v=1"> </script>    
    <script type="text/javascript" src="/portal/portal3rc.fcgi/static/js/hfjs2.js"> </script>
</div>
                        </div>
                    </div>
                    <!--/.page-->
                </div>
                <!--/.wrap-->
            </div><!-- /.twelve_col -->
        </div>
        <!-- /.grid -->

        <span class="PAFAppResources"></span>
        
        <!-- BESelector tab -->
        
        
        
        <noscript><img alt="statistics" src="/stat?jsdisabled=true&amp;ncbi_db=books&amp;ncbi_pdid=book-part&amp;ncbi_acc=NBK1268&amp;ncbi_domain=gene&amp;ncbi_report=record&amp;ncbi_type=fulltext&amp;ncbi_objectid=&amp;ncbi_pcid=/NBK1268/&amp;ncbi_pagename=Spinocerebellar Ataxia Type 8 - GeneReviews® - NCBI Bookshelf&amp;ncbi_bookparttype=chapter&amp;ncbi_app=bookshelf" /></noscript>
        
        
        <!-- usually for JS scripts at page bottom -->
        <!--<component id="PageFixtures" label="styles"></component>-->
    

<!-- CE8C6712E040D581_2159SID /projects/books/PBooks@5.22 portal105 v4.1.r585844 Mon, May 06 2019 02:53:16 -->

<script type="text/javascript" src="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/js/3879255/4121861/3501987/4008961/3893018/3821238/4062932/4123007/4087685/4076480/3921943/3400083/3426610.js" snapshot="books"></script></body>
</html>